≡ Risteys
FG R12 + FR

Documentation Changelog GitHub Contact & Feedback
info icon

Right hemicolectomy

Endpoint Browser

OPER_JFB30

Endpoint definition

↥

Endpoint definition steps

FinnGen

Phenotype data

520210

1. Apply sex-specific rule

None

520210

2. Check conditions

None

520210

3. Check pre-conditions, main-only, mode, registry filters

Registry filters:

  • Operations: NOMESCO codes — ^JFB30

1 out of 7 registries used, show all original rules.

2190

4. Check minimum number of events

None

2190

5. Include endpoints

None

2190

6. Filter based on genotype QC (FinnGen only)

2190

Control definitions (FinnGen only)

Controls for this endpoint are individuals that are not cases.

Extra metadata

First used in FinnGen datafreeze
DF2

Case counts by codes

↥

FinnGen case counts by registry codes:

generic upset plot

Upset plot

Full data table

Summary Statistics

↥

-FinRegistry-

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

-FinnGen-

Key figures

All Female Male
Number of individuals 2190 1024 1166
Unadjusted period prevalence (%) 0.44 0.35 0.51
Median age at first event (years) 68.83 67.17 70.29

-FinnGen-

Age distribution of first events

-FinnGen-

Year distribution of first events

-FinnGen-

Cumulative Incidence Function

Not a core endpoint, no data to show.

CodeWAS (R11)

↥

CodeWAS is a tool for exploring the associations between an endpoint and all of the medical codes and drug codes.

This is a new tool, please reach out using the contact form for feedback and improvement ideas.

First, a cohort is built by matching controls to the endpoint cases using year of birth and sex. Then, a Fisher test is done for all the medical codes and drug codes between the cases and controls of this cohort. Codes are reported in the table below if they have −log10(p-value) ≥ 6.

Matched cohort

Matched cases
1999
Matched controls
19989
Code
Vocabulary
Description
Odds Ratio
-log10(p)
N matched cases
N matched controls
JFB30
NOMESCO Finland
Right hemicolectomy
+∞
323.0
1999
*
C18.01
ICD-10 Finland
Malignant tumor of the caecum invasive carcinoma
102.4
323.0
403
49
UJF32
NOMESCO Finland
Coloscopy
7.2
323.0
1235
3670
WX302
NOMESCO Finland
Thoracal epidural anesthesy
15.4
308.6
541
469
C18.21
ICD-10 Finland
Malignant tumor of the ascending colon invasive carcinoma
80.9
306.6
343
51
8140/3-C18.2
ICD-O-3
Adenocarcinoma, NOS, of ascending colon
97.7
292.9
320
39
C18.00
ICD-10 Finland
Malignant tumor of the caecum without histology
97.3
291.8
319
39
130
Kela drug reimbursment
Malignant tumour
9.5
288.5
670
1009
C18.20
ICD-10 Finland
Malignant tumor of the ascending colon without histology
89.3
287.0
317
42
L01BC06
ATC
capecitabine; oral
20.1
283.3
442
278
8140/3-C18.0
ICD-O-3
Adenocarcinoma, NOS, of cecum
86.0
218.4
243
32
D37.4
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Colon
22.0
176.6
264
137
WX602
NOMESCO Finland
Repeated or continuing anesthesia shots throug a catheter
8.1
173.2
424
639
JN4BD
NOMESCO Finland
Extensive body CT
5.4
164.2
576
1394
JN3BD
NOMESCO Finland
Extensive abdominal CT
5.8
161.0
524
1158
K56.6
ICD-10 Finland
Other and unspecified intestinal obstruction
10.9
146.8
296
313
C18.31
ICD-10 Finland
Malignant tumor of flexura hepatica invasive carcinoma
107.2
137.1
149
15
WX408
NOMESCO Finland
General anesthesy, balanced
3.5
134.6
851
3470
C18.09
ICD-10 Finland
Malignant tumor of caecum other or unspecified histology
126.3
131.9
141
12
B01AB05
ATC
enoxaparin; parenteral
3.3
128.2
964
4433
A03FA01
ATC
metoclopramide; systemic, rectal
3.6
123.8
711
2645
C18.29
ICD-10 Finland
Malignant tumor of the ascending colon or other unspecified histology
91.2
122.8
136
16
C18.30
ICD-10 Finland
Malignant tumor of flexura hepatica without histology
101.7
121.7
133
14
C18.41
ICD-10 Finland
Malignant tumor of the transverse colon invasive carcinoma
76.5
120.2
136
19
JAH00
NOMESCO Finland
Laparotomy
11.0
114.5
228
231
C18.0
ICD-10 Finland
Malignant neoplasm: Caecum
128.7
113.4
121
10
R10.4
ICD-10 Finland
Other and unspecified abdominal pain
3.0
107.8
911
4382
TPH07
NOMESCO Finland
Cathetrisation of artery
4.2
102.8
453
1310
TPH15
NOMESCO Finland
Insertion of central venous catheter through external or internal jugular vein
6.0
100.9
301
570
C18.99
ICD-10 Finland
Malignant tumor in unspecified location in the colon other or unspecified histology
55.4
100.9
120
23
A04AA02
ATC
granisetron; systemic, transdermal
6.1
100.4
298
561
8140/3-C18.4
ICD-O-3
Adenocarcinoma, NOS, of transverse colon
72.5
96.5
110
16
C18.11
ICD-10 Finland
Malignant tumor of the appendix invasive carcinoma
100.7
96.0
105
11
JN4AD
NOMESCO Finland
Body CT examination
4.8
95.7
353
851
C18.2
ICD-10 Finland
Malignant neoplasm: Ascending colon
78.4
92.2
104
14
JN3AD
NOMESCO Finland
Abdominal CT examination
4.8
91.0
335
803
JFF13
NOMESCO Finland
Terminal enterostomy
156.9
85.8
90
6
K56.2
ICD-10 Finland
Volvulus
29.9
85.7
116
41
JFB00
NOMESCO Finland
Partial resection of small intestine
12.3
83.5
156
137
8140/3-C18.3
ICD-O-3
Adenocarcinoma, NOS, of hepatic flexure of colon
179.5
82.8
86
5
ZXD05
NOMESCO Finland
Urgent procedure
2.6
82.3
834
4276
C18.10
ICD-10 Finland
Malignant tumor of the appendix without histology
94.2
81.7
90
10
H02AB02
ATC
dexamethasone; systemic
3.9
81.2
376
1115
WD125
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
6.5
79.4
220
374
JAL20
NOMESCO Finland
Excision or destruction of lesion of peritoneum
51.6
74.1
89
18
D64.9
ICD-10 Finland
Anaemia, unspecified
3.3
73.3
422
1481
JAH01
NOMESCO Finland
Laparoscopy
6.6
71.7
194
318
C18.22
ICD-10 Finland
Malignant tumor of the colon ascending carcinoma of the adenoma
91.4
71.5
79
9
Z08.0
ICD-10 Finland
Follow-up examination after surgery for malignant neoplasm
9.0
70.5
155
185
C18.40
ICD-10 Finland
Malignant tumor of the transverse colon without histology
57.6
70.4
83
15
JAL30
NOMESCO Finland
Omentectomy
17.0
68.2
110
68
WB113
NOMESCO Finland
Multiple adjuvant cytostatic therapy
6.1
68.0
196
349
UJD10
NOMESCO Finland
Esophagoscopy, gastroscopy and duodenoscopy
2.4
67.1
784
4214
C78.7
ICD-10 Finland
Secondary malignant neoplasm of liver and intrahepatic bile duct
8.8
65.5
146
178
D50.9
ICD-10 Finland
Iron deficiency anaemia, unspecified
3.9
65.3
294
839
ZXE20
NOMESCO Finland
More than three and less than five hours
3.0
65.3
443
1729
JKA20
NOMESCO Finland
Cholecystectomy
6.5
65.0
178
296
K56.5
ICD-10 Finland
Intestinal adhesions [bands] with obstruction
9.7
63.9
134
147
C18.19
ICD-10 Finland
Malignant tumor in appendix other or unspecified histology
81.8
63.4
71
9
JF1AB
NOMESCO Finland
Passage examination of small bowell with X-ray
12.2
63.0
117
101
C79.8
ICD-10 Finland
Secondary malignant neoplasm of other specified sites
6.3
62.7
175
298
JN3AA
NOMESCO Finland
Abdominal X-ray examination without contrast
5.0
62.0
214
470
C18.90
ICD-10 Finland
Malignant tumor in unspecified location in the colon without histology
33.3
60.9
80
25
C18.02
ICD-10 Finland
Malignant tumor of caecum carcinoma of adenoma
46.6
59.0
72
16
8140/3-C18.9
ICD-O-3
Adenocarcinoma, NOS, of colon, NOS
25.8
58.5
82
33
K63.1
ICD-10 Finland
Perforation of intestine (nontraumatic)
14.6
58.4
100
72
TPH04
NOMESCO Finland
Cathetrisation of vein
2.4
55.8
574
2830
TPH20
NOMESCO Finland
Insertion of central venous catheter through subclavian or brachiocephalic vein
7.0
55.1
142
216
K56.7
ICD-10 Finland
Ileus, unspecified
8.8
54.8
121
145
K43.9
ICD-10 Finland
Other and unspecified ventral hernia without obstruction or gangrene
4.6
54.5
204
486
D75
ICPC
Malignant neoplasm colon/rectum
16.7
52.5
85
53
8480/3-C18.1
ICD-O-3
Mucinous adenocarcinoma of appendix
272.7
52.4
53
*
B01AB10
ATC
tinzaparin; parenteral
3.8
51.9
241
700
ZXE10
NOMESCO Finland
More than one and less than three hours
2.1
50.9
850
5206
WZC20
NOMESCO Finland
Multidisciplinary treatment meeting
4.3
50.3
200
504
Z98.0
ICD-10 Finland
Intestinal bypass and anastomosis status
25.8
50.1
70
28
C78.6
ICD-10 Finland
Secondary malignant neoplasm of retroperitoneum and peritoneum
14.5
49.7
85
61
UJF45
NOMESCO Finland
Flexible sigmoidoscopy with biopsy
3.3
49.2
272
905
JFF10
NOMESCO Finland
Loop enterostomy
21.9
49.0
72
34
UJF30
NOMESCO Finland
Ileoscopy through colon
3.2
48.4
278
951
WD405
NOMESCO Finland
Simple antiboidy therapy of methastized malignancy
7.4
48.2
119
170
JAP00
NOMESCO Finland
Freeing of adhesions in the peritoneal cavity
13.0
47.4
85
68
ZX120
NOMESCO Finland
Intravenous
3.1
47.3
290
1038
D37.3
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Appendix
60.4
45.5
53
9
K65.0
ICD-10 Finland
Acute peritonitis
10.4
45.1
90
90
C18.39
ICD-10 Finland
Malignant tumor of flexura hepatica other or unspecified histology
85.5
45.0
50
6
JN3AE
NOMESCO Finland
Abdominal ultrasound examination
2.6
45.0
372
1604
8480/3-C18.0
ICD-O-3
Mucinous adenocarcinoma of cecum
122.9
44.9
48
*
GD1UA
NOMESCO Finland
Thorax X-ray examination outside radiological department
2.4
44.8
448
2139
JWA00
NOMESCO Finland
Repair of wound dehiscence in gastroenterological surgery
18.8
44.7
69
38
TPX10
NOMESCO Finland
Implantation of vascular injection port
6.2
44.3
124
211
XF603
NOMESCO Finland
Direct intraarterial blood pressure measurement
4.7
43.3
155
351
ZXK00
NOMESCO Finland
Conversion from percutaneous endoscopic to open procedure
16.6
42.7
69
43
JA3AT
NOMESCO Finland
Cathetrisation of abdominal cavity with ultrasound guidance
9.3
42.4
90
101
WD105
NOMESCO Finland
Cystostatic therapy of methastized malignancy
4.5
41.4
153
358
WX704
NOMESCO Finland
Intubation
3.4
41.3
217
692
D50.0
ICD-10 Finland
Iron deficiency anaemia secondary to blood loss (chronic)
4.8
41.2
144
318
C17.9
ICD-10 Finland
Malignant neoplasm: Small intestine, unspecified
23.3
41.1
59
26
K50.0
ICD-10 Finland
Crohn disease of small intestine
11.7
41.1
77
68
A02BC02
ATC
pantoprazole; systemic
1.9
40.6
1346
10340
Z51.5
ICD-10 Finland
Palliative care
3.3
40.5
225
745
WZC30
NOMESCO Finland
Teaching
2.6
40.4
336
1446
WD415
NOMESCO Finland
Demanding antibody therapy of methastized malignancy
9.1
39.6
85
97
JAD30
NOMESCO Finland
Repair of incisional hernia using prosthetic material
7.1
39.3
99
146
JN4CD
NOMESCO Finland
Very extensive body CT
4.3
39.0
152
374
K50.8
ICD-10 Finland
Other Crohn disease
10.0
38.9
79
82
T81.4
ICD-10 Finland
Infection following a procedure, not elsewhere classified
2.7
38.8
293
1191
WX402
NOMESCO Finland
General anaesthesia
2.4
38.4
367
1697
A04AA01
ATC
ondansetron; systemic, rectal
3.4
37.6
194
608
C18.91
ICD-10 Finland
Malignant tumor of unspecified location in colon invasive carcinoma
45.9
37.0
45
10
TJD00
NOMESCO Finland
Insertion of nasogastric or naso-gastroduodenal tube
9.0
36.7
79
91
GD1AA
NOMESCO Finland
Thorax X-ray examination
1.8
36.7
994
7004
WW500
NOMESCO Finland
Blood transfusion
4.1
36.6
149
382
N02BE01
ATC
paracetamol; systemic, rectal
2.2
36.3
1716
14695
JFA15
NOMESCO Finland
Endoscopic polypectomy in colon
3.5
36.2
184
570
WX600
NOMESCO Finland
Single shot through catheter
11.0
35.7
69
65
D12.2
ICD-10 Finland
Benign neoplasm: Ascending colon
4.5
35.5
130
301
JFB33
NOMESCO Finland
Other resection comprising small intestine and colon
31.3
34.8
46
15
N02AA05
ATC
oxycodone; systemic
2.2
34.5
410
2096
D37.2
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Small intestine
16.1
33.9
55
35
WZC00
NOMESCO Finland
Planning of intervention or health care consultation
1.9
33.1
664
4173
C18
ICD-10 Finland
Malignant neoplasm of colon
49.6
32.6
39
8
K55.0
ICD-10 Finland
Acute vascular disorders of intestine
11.6
32.1
60
53
D12.0
ICD-10 Finland
Benign neoplasm: Caecum
5.2
32.1
102
203
WX306
NOMESCO Finland
Lumbar epidural anesthesy
3.9
32.0
137
368
K50.1
ICD-10 Finland
Crohn disease of large intestine
10.1
31.9
64
65
C18.4
ICD-10 Finland
Malignant neoplasm: Transverse colon
111.8
30.7
33
*
K56.0
ICD-10 Finland
Paralytic ileus
8.1
30.7
70
89
E34.0
ICD-10 Finland
Carcinoid syndrome
36.1
30.6
39
11
JN1AE
NOMESCO Finland
Ultrasound examination of upper part of abdomen
2.7
30.3
223
885
K50.9
ICD-10 Finland
Crohn disease, unspecified
8.6
30.1
66
79
C18.3
ICD-10 Finland
Malignant neoplasm: Hepatic flexure
69.0
30.0
34
5
C18.9
ICD-10 Finland
Malignant neoplasm: Colon, unspecified
69.0
30.0
34
5
D12.6
ICD-10 Finland
Benign neoplasm: Colon, unspecified
3.1
29.9
175
599
D12.5
ICD-10 Finland
Benign neoplasm: Sigmoid colon
3.5
29.8
144
428
WB103
NOMESCO Finland
Simple adjuvant cytostatic therapy
4.2
28.4
111
274
JN3CD
NOMESCO Finland
Abdominal CT examination both without and with contrast
3.8
28.4
126
349
T81.3
ICD-10 Finland
Disruption of operation wound, not elsewhere classified
5.1
28.3
91
184
K35.1
ICD-10 Finland
Acute appendicitis with peritoneal abscess
9.3
28.2
59
65
601
Kela drug reimbursment
Severe malabsorption of nutrients, mainly fats
10.4
28.0
55
54
WX404
NOMESCO Finland
Intravenous generell anesthesy
2.0
27.9
412
2286
C18.32
ICD-10 Finland
Malignant tumor of flexura hepatica carcinoma of adenoma
147.0
27.7
29
*
C18.49
ICD-10 Finland
Malignant tumor of the transverse colon other or unspecified histology
147.0
27.7
29
*
QBB10
NOMESCO Finland
Major dressing of wound of skin of trunk
4.1
27.5
110
278
ZXE30
NOMESCO Finland
More than five and less than seven hours
3.2
27.4
150
490
JFA98
NOMESCO Finland
Other transluminal endoscopic local operation on intestine
5.2
27.0
85
168
C18.1
ICD-10 Finland
Malignant neoplasm: Appendix
76.2
26.8
30
*
WB123
NOMESCO Finland
Demanding adjuvant cytostatic therapy
8.7
26.8
58
68
8480/3-C18.2
ICD-O-3
Mucinous adenocarcinoma of ascending colon
98.1
26.7
29
*
C10AC01
ATC
colestyramine; oral
4.4
25.9
97
230
1XC07
NOMESCO Finland
NA
25.4
25.3
35
14
JFC10
NOMESCO Finland
Ileotransversostomy
58.8
25.0
29
5
JFG00
NOMESCO Finland
Closure of loop enterostomy without resection
16.3
25.0
40
25
S18
ICPC
Laceration/cut
1.7
24.9
851
6172
P01AB01
ATC
metronidazole; oral, rectal
1.7
24.8
714
4928
C78.0
ICD-10 Finland
Secondary malignant neoplasm of lung
5.1
24.4
78
157
WX892
NOMESCO Finland
Monitored bed care
2.5
23.8
203
874
Z93.2
ICD-10 Finland
Ileostomy status
21.6
23.5
34
16
1506
Kela drug reimbursment
The combination of trifluridine and tipiracil
47.3
23.3
28
6
K35.9
ICD-10 Finland
Acute appendicitis, unspecified
3.1
23.3
137
469
JWF00
NOMESCO Finland
Reoperation for insufficiency of anastomosis or suture in gastroenterological surgery
22.3
23.0
33
15
C18.42
ICD-10 Finland
Malignant tumor of the transverse colon carcinoma of the adenoma
65.7
22.9
26
*
R10.0
ICD-10 Finland
Acute abdomen
4.0
22.7
94
246
C17.2
ICD-10 Finland
Malignant neoplasm: Ileum
20.9
22.6
33
16
D12.3
ICD-10 Finland
Benign neoplasm: Transverse colon
4.2
22.6
87
213
3018
Kela drug reimbursment
The combination of trifluridine and tipiracil
45.5
22.4
27
6
JAH33
NOMESCO Finland
Opening of laparostomy
45.5
22.4
27
6
A49.9
ICD-10 Finland
Bacterial infection, unspecified
2.1
22.3
289
1511
JFB46
NOMESCO Finland
Resection of sigmoid colon
6.2
22.2
60
99
R4110
NOMESCO Finland
Physiotherapy
1.7
22.1
545
3567
C18.12
ICD-10 Finland
Malignant tumor of the appendix carcinoma of the adenoma
63.2
21.9
25
*
JMA10
NOMESCO Finland
Transabdominal total splenectomy
10.7
21.9
42
40
208
Kela drug reimbursment
Ulcerative colitis and Crohn's disease
3.5
21.7
105
313
R19.0
ICD-10 Finland
Intra-abdominal and pelvic swelling, mass and lump
4.5
21.7
79
183
GD1PA
NOMESCO Finland
X-ray examination of the lungs in one projection
2.2
21.6
231
1107
R4190
NOMESCO Finland
Nutritional therapy
4.1
21.6
87
222
L01BC59
ATC
trifluridine, combinations; systemic
43.8
21.4
26
6
R10.3
ICD-10 Finland
Pain localized to other parts of lower abdomen
1.9
21.2
342
1945
JFG26
NOMESCO Finland
Closure of terminal enterostomy with anastomosis to colon
212.0
20.6
21
*
UJF34
NOMESCO Finland
Left colonoscopy
8.2
20.2
45
56
WX872
NOMESCO Finland
Intensive care
2.7
20.2
142
546
A09
ICD-10 Finland
Other gastroenteritis and colitis of infectious and unspecified origin
1.9
19.5
322
1839
ZXE50
NOMESCO Finland
More than nine and less than 12 hours
4.7
19.5
67
147
H01CB03
ATC
lanreotide; parenteral
15.7
19.3
31
20
8240/3-C17.2
ICD-O-3
Neuroendocrine tumor, NOS, of ileum
46.5
19.2
23
5
ZXE02
NOMESCO Finland
Procedure duration 10 to 19 minutes
2.9
18.9
118
421
D12.8
ICD-10 Finland
Benign neoplasm: Rectum
3.0
18.8
112
387
D12.4
ICD-10 Finland
Benign neoplasm: Descending colon
4.8
18.7
62
131
GD1QA
NOMESCO Finland
Supine thorax X-ray examination
1.8
18.7
403
2512
J01MA12
ATC
levofloxacin; systemic
1.7
18.7
411
2581
XZZ00
NOMESCO Finland
Active surveillance of a diagnosed cancer
5.5
18.6
55
102
WX882
NOMESCO Finland
High dependency care
3.5
18.6
90
269
WX700
NOMESCO Finland
Respiratory and circulatory monitoring
1.8
18.6
348
2075
Z3231
NOMESCO Finland
Registered nurse
1.6
18.5
557
3820
JEA00
NOMESCO Finland
Appendectomy
2.7
18.5
127
483
N02AX02
ATC
tramadol; systemic, rectal
1.5
18.4
834
6339
JFF23
NOMESCO Finland
Transversostomy
6.1
18.3
50
84
D77
ICPC
Malignant digestive neopl other/NOS
13.7
18.2
31
23
JFF30
NOMESCO Finland
Other colostomy
44.4
18.2
22
5
Z80.0
ICD-10 Finland
Family history of malignant neoplasm of digestive organs
15.5
18.0
29
19
Y83.9
ICD-10 Finland
Surgical procedure, unspecified as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
3.8
17.7
77
211
H01CB02
ATC
octreotide; parenteral
14.7
17.6
29
20
ZXM00
NOMESCO Finland
Intraoperative use of ultrasonographic imaging
7.2
17.6
42
59
ZXE40
NOMESCO Finland
More than seven and less than nine hours
3.7
17.5
77
214
K92.1
ICD-10 Finland
Melaena
2.5
17.4
146
621
Z3226
NOMESCO Finland
Physiotherapist
1.7
17.4
376
2343
166
Kela drug reimbursment
Dalteparin and tinzaparin (treatment for more than 6 months)
7.8
17.1
39
51
T81.8
ICD-10 Finland
Other complications of procedures, not elsewhere classified
4.6
16.9
59
132
ZXD10
NOMESCO Finland
Scheduled procedure
1.5
16.7
743
5584
D48.42
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum originating in the appendix
171.3
16.5
17
*
C18.71
ICD-10 Finland
Malignant tumor of the sigmoid invasive carcinoma
4.6
16.4
57
127
JWW96
NOMESCO Finland
Other reoperation in gastroenterological surgery
23.2
16.4
23
10
K57.3
ICD-10 Finland
Diverticular disease of large intestine without perforation or abscess
1.7
16.4
391
2502
JF1AD
NOMESCO Finland
Small bowel CT
12.2
16.3
29
24
SPAT1153
SPAT
Removal of sutures
1.6
16.3
630
4574
JJB10
NOMESCO Finland
Atypcal resection of liver
15.5
16.2
26
17
B03BA03
ATC
hydroxocobalamin; parenteral
2.3
16.0
158
730
D37.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other digestive organs
3.7
16.0
71
199
WD115
NOMESCO Finland
Multiple cystostatic therapy of methastized malignancy
4.2
15.9
61
150
L04AX01
ATC
azathioprine; systemic
2.9
15.8
96
339
JN7AQ
NOMESCO Finland
Somatostatin receptor SPET med low dose CT
33.6
15.7
20
6
XX7JT
NOMESCO Finland
Somatostatin isotope ablative therapy
33.6
15.7
20
6
XX4AT
NOMESCO Finland
Other canalization with ultrasound guidance
15.8
15.7
25
16
GD1BD
NOMESCO Finland
Thorax extensive CT-examination
2.4
15.3
136
597
A04AA55
ATC
palonosetron, combinations; systemic
3.7
15.3
66
181
326
Kela drug reimbursment
Adalimumab, golimumab, infliximab and ustekinumab (intestinal diseases)
13.1
15.2
26
20
GA4YT
NOMESCO Finland
Puncture of pleura with ultrasound guidance
3.0
15.0
86
292
R11
ICD-10 Finland
Nausea and vomiting
2.1
14.9
169
830
TQW11
NOMESCO Finland
Vacuum treatment of wound
3.9
14.9
61
160
JA2AT
NOMESCO Finland
Abdominal puncture with ultrasound guidance
7.0
14.9
36
52
JF1BD
NOMESCO Finland
Very extensive small bowel CT
8.0
14.8
33
42
JFA70
NOMESCO Finland
Suture of small intestine
11.4
14.8
27
24
N02AB03
ATC
fentanyl; nasal, sublingual, transdermal
2.4
14.7
123
523
8480/3-C18.3
ICD-O-3
Mucinous adenocarcinoma of hepatic flexure of colon
+∞
14.6
14
*
8480/1-C18.1
ICD-O-3
Low grade appendiceal mucinous neoplasm of appendix
80.7
14.6
16
*
SPAT1144
SPAT
Treatment of reopened or infected surgical wound
2.1
14.5
166
820
JN5DR
NOMESCO Finland
PET-CT of upper body metabolism
4.7
14.3
48
104
KBV02
NOMESCO Finland
Cystoscopic insertion of stent into ureter
3.5
14.2
66
193
WX002
NOMESCO Finland
Sedation and analgesia
1.6
14.1
403
2700
Y83
ICD-10 Finland
Surgical operation and other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.1
14.1
174
887
A07EA06
ATC
budesonide; oral, local oral
3.1
14.0
78
261
TPX15
NOMESCO Finland
Removal of vascular injection port
15.9
13.9
22
14
QBB05
NOMESCO Finland
Revision of wound of skin of trunk
5.9
13.9
38
65
K63.0
ICD-10 Finland
Abscess of intestine
30.2
13.9
18
6
SPAT1125
SPAT
Stoma care and guidance
3.9
13.8
57
151
N13.3
ICD-10 Finland
Other and unspecified hydronephrosis
3.8
13.8
58
156
K91.4
ICD-10 Finland
Colostomy and enterostomy malfunction
23.9
13.8
19
8
TJF80
NOMESCO Finland
Ostomy education
6.1
13.8
37
62
R10.1
ICD-10 Finland
Pain localized to upper abdomen
1.7
13.7
289
1776
R50.9
ICD-10 Finland
Fever, unspecified
1.8
13.7
265
1589
LAF10
NOMESCO Finland
Bilateral salpingo-oophorectomy
3.0
13.6
80
277
TPH90
NOMESCO Finland
Removal of fixed intravenous catheter
5.6
13.6
39
71
ZXD31
NOMESCO Finland
Major difficulties in performing procedure
3.1
13.5
75
251
Z2446
NOMESCO Finland
Social worker
2.3
13.5
129
589
B01AB04
ATC
dalteparin; parenteral
2.3
13.2
124
560
A07EC02
ATC
mesalazine; oral, rectal
2.5
13.1
106
441
L03AA02
ATC
filgrastim; parenteral
3.3
13.0
64
196
JFB40
NOMESCO Finland
Resection of transverse colon
16.8
13.0
20
12
369
Kela drug reimbursment
Regorafenib
16.8
13.0
20
12
ZXE03
NOMESCO Finland
Procedure duration 20 to 29 minutes
2.2
13.0
128
593
L01XE21
ATC
[U] regorafenib; oral
22.7
12.9
18
8
JFG10
NOMESCO Finland
Closure of loop colostomy without resection
5.7
12.8
36
64
WX725
NOMESCO Finland
Noninvasive ventilation
2.5
12.8
98
397
JJA20
NOMESCO Finland
Open biopsy of liver
11.6
12.8
23
20
R18
ICD-10 Finland
Ascites
3.6
12.8
57
162
JN1CG
NOMESCO Finland
Extensive MRI examination of upper part of abdomen with high intensity magnet
3.4
12.7
61
184
J01MA02
ATC
ciprofloxacin; systemic
1.4
12.7
760
5982
176
Kela drug reimbursment
Regorafenib
15.5
12.6
20
13
C20.91
ICD-10 Finland
Malignant tumor of the rectum invasive carcinoma
3.0
12.6
72
245
A79
ICPC
Malignancy NOS
4.4
12.6
45
105
ZXE60
NOMESCO Finland
More than 12 and less than 15 hours
5.7
12.5
35
62
JFB31
NOMESCO Finland
Laparoscopic right hemicolectomy
4.4
12.5
44
101
D39.10
ICD-10 Finland
Tumor of uncertain or unknown nature in the ovary without histology
3.5
12.3
56
162
D12.1
ICD-10 Finland
Benign neoplasm: Appendix
14.4
12.3
20
14
XX9AN
NOMESCO Finland
Complementary isotope examination or additional picture
18.1
12.0
18
10
JN3KE
NOMESCO Finland
Abdominal ultrasound with added contrast
8.0
11.8
26
33
JFG40
NOMESCO Finland
Revision of enterostomy or colostomy without laparotomy
14.7
11.8
19
13
FB1BD
NOMESCO Finland
Extensive CT examination of arteria pulmonalis
1.9
11.6
162
866
IAZ97
NOMESCO Finland
Psychiatric consultation in another specialty
6.5
11.6
29
45
D01
ICPC
Abdominal pain/cramps general
1.9
11.6
171
935
JGB03
NOMESCO Finland
Partial proctectomy with partial excision of mesorectum
9.3
11.5
23
25
LAE10
NOMESCO Finland
Unilateral oophorectomy
13.7
11.4
19
14
JJ2AT
NOMESCO Finland
Biopsy of liver with ultrasound guidance
3.4
11.4
53
157
JFB50
NOMESCO Finland
Other resection of colon
15.1
11.3
18
12
ZXE04
NOMESCO Finland
Procedure duration 30 to 39 minutes
2.2
11.2
118
562
J18.9
ICD-10 Finland
Pneumonia, unspecified
1.5
11.0
530
3968
WD135
NOMESCO Finland
Demanding cystostatic therapy of methastized malignancy
5.8
11.0
30
52
JF1CG
NOMESCO Finland
Extensive MRI of small bowel
8.6
11.0
23
27
JA3CT
NOMESCO Finland
Cathetrisation of abdominal cavity with CT guidance
43.5
10.9
13
*
I26.9
ICD-10 Finland
Pulmonary embolism without mention of acute cor pulmonale
2.1
10.9
125
620
L03AA13
ATC
pegfilgrastim; parenteral
2.7
10.9
74
284
K50
ICD-10 Finland
Crohn disease [regional enteritis]
15.6
10.8
17
11
8140/3-C18.8
ICD-O-3
Adenocarcinoma, NOS, of overlapping lesion of colon
60.3
10.6
12
*
C79.6
ICD-10 Finland
Secondary malignant neoplasm of ovary
60.3
10.6
12
*
K92.2
ICD-10 Finland
Gastrointestinal haemorrhage, unspecified
2.7
10.6
72
276
JA3BT
NOMESCO Finland
Cathetrisation of abdominal cavity with X-ray guidance
10.1
10.5
20
20
C18.50
ICD-10 Finland
Malignant tumor in flexural lienalis without histology
14.3
10.5
17
12
Z04.8
ICD-10 Finland
Examination and observation for other specified reasons
1.8
10.5
201
1198
D01.0
ICD-10 Finland
Carcinoma in situ: Colon
110.5
10.4
11
*
JFB63
NOMESCO Finland
Other resection of colon with proximal colostomy and closure of distal stump
+∞
10.4
10
*
128
Kela drug reimbursment
Cancers of female genital organs
3.6
10.4
45
126
A04AD12
ATC
aprepitant; systemic
3.7
10.4
44
121
WX000
NOMESCO Finland
Monitoring vital functions without anesthesy
2.5
10.4
77
310
8240/3-C18.1
ICD-O-3
Neuroendocrine tumor, NOS, of appendix
32.7
10.3
13
*
J01DB01
ATC
cefalexin; oral
1.4
10.3
1452
13073
K91.2
ICD-10 Finland
Postsurgical malabsorption, not elsewhere classified
18.9
10.3
15
8
A41.9
ICD-10 Finland
Sepsis, unspecified
2.3
10.2
91
403
SPAT1083
SPAT
Initiation and monitoring of IV fluid therapy
2.2
10.1
101
474
8140/3-C18.1
ICD-O-3
Adenocarcinoma, NOS, of appendix
40.3
10.0
12
*
T81.2
ICD-10 Finland
Accidental puncture and laceration during a procedure, not elsewhere classified
4.9
9.9
31
64
JF1DG
NOMESCO Finland
Small bowel very extensive MRI with with high intensity magnet
26.1
9.8
13
5
Z93.3
ICD-10 Finland
Colostomy status
5.7
9.8
27
48
K63.2
ICD-10 Finland
Fistula of intestine
20.1
9.8
14
7
JN1DG
NOMESCO Finland
Very extensive MRI examination of upper part of abdomen with high intensity magnet
3.5
9.7
44
128
JAQ10
NOMESCO Finland
Intraoperative hypertermic chemotherapeutic perfusion of abdominal cavity
55.2
9.6
11
*
D64.8
ICD-10 Finland
Other specified anaemias
3.3
9.6
46
140
LCD00
NOMESCO Finland
Hysterectomy
2.4
9.6
82
356
JFK10
NOMESCO Finland
Freeing of adhesions in intestinal obstruction
7.8
9.6
21
27
LAF00
NOMESCO Finland
Unilateral salpingo-oophorectomy
5.2
9.5
28
54
JFA58
NOMESCO Finland
Endoscopic dilatation of colon
15.1
9.5
15
10
ZXD30
NOMESCO Finland
Difficulties in perfomrming procedure
2.2
9.4
89
406
8249/3-C17.2
ICD-O-3
Neuroendocrine tumor, grade 2 of ileum
100.5
9.4
10
*
K55.9
ICD-10 Finland
Vascular disorder of intestine, unspecified
7.6
9.4
21
28
Z85.0
ICD-10 Finland
Personal history of malignant neoplasm of digestive organs
12.4
9.4
16
13
8461/3-C57.0
ICD-O-3
High grade serous carcinoma of fallopian tube
21.8
9.3
13
6
C56.71
ICD-10 Finland
Serous epithelial malignant tumor of the ovary
4.7
9.3
30
64
E0000UV
ATC
NA
1.4
9.2
644
5132
3AC01
NOMESCO Finland
NA
4.7
9.2
30
65
JFB43
NOMESCO Finland
Left hemicolectomy
4.8
9.2
29
61
N10
ICD-10 Finland
Acute tubulo-interstitial nephritis
1.6
9.1
261
1736
B81
ICPC
Anaemia vit B12/folate deficiency
2.2
9.1
91
426
C18.51
ICD-10 Finland
Malignant tumor of flexura hiealis invasive carcinoma
11.5
9.1
16
14
TKC20
NOMESCO Finland
Catheterisation of bladder
1.8
9.0
156
901
D99
ICPC
Disease digestive system other
4.7
9.0
29
62
JWC00
NOMESCO Finland
Reoperation for deep infection in gastroenterological surgery
15.6
9.0
14
9
T81.9
ICD-10 Finland
Unspecified complication of procedure
3.2
9.0
45
142
D78
ICPC
Neoplasm digestive benign/unspecif
18.7
8.9
13
7
JAD11
NOMESCO Finland
Laparoscopic repair of incisional hernia
3.9
8.9
35
91
KBV12
NOMESCO Finland
Transluminal endoscopic removal of stent from ureter
3.9
8.9
35
91
ZXE11
NOMESCO Finland
Procedure duration 60 to 89 minutes
2.2
8.9
87
403
SPAT1255
SPAT
Intravenous administration of medicine
1.9
8.9
130
708
GA1AE
NOMESCO Finland
Ultrasound examination of thorax
2.8
8.8
56
207
C20.90
ICD-10 Finland
Malignant tumor of the rectum without histology
3.3
8.8
43
134
ZX100
NOMESCO Finland
Oral
3.8
8.7
35
93
A09AA02
ATC
multienzymes (lipase, protease etc.)
3.0
8.7
48
163
C56.00
ICD-10 Finland
Malignant tumor of the ovary without histology
6.2
8.6
22
36
JFK00
NOMESCO Finland
Division of adhesive band in intestinal obstruction
11.6
8.6
15
13
Y69
ICD-10 Finland
Unspecified misadventure during surgical and medical care
4.0
8.5
32
80
QBG30
NOMESCO Finland
Delayed skin closure of surgical wound in trunk
16.3
8.5
13
8
L01BC53
ATC
tegafur, combinations; systemic
16.3
8.5
13
8
WD505
NOMESCO Finland
Simple enzyme inhibitor or similar therapy of methastized malignancy
4.4
8.5
29
66
V03AF03
ATC
calcium folinate; systemic
9.0
8.5
17
19
E11.9
ICD-10 Finland
Type 2 diabetes mellitus, without complications
1.4
8.5
482
3695
KH1AE
NOMESCO Finland
Urinary tract ultrasound examination
1.9
8.5
115
609
WB121
NOMESCO Finland
Demanding neoadjuvant cytostatic therapy
4.7
8.4
27
58
JAK03
NOMESCO Finland
Laparotomy and peritoneal irrigation
12.8
8.4
14
11
Z31.5
ICD-10 Finland
Genetic counselling
2.5
8.3
61
245
8240/3-C18.0
ICD-O-3
Neuroendocrine tumor, NOS, of cecum
+∞
8.3
8
*
XX1AT
NOMESCO Finland
Other puncture with ultrasound guidance
4.3
8.3
29
68
C03CA01
ATC
furosemide; systemic
1.3
8.3
678
5521
JAG60
NOMESCO Finland
Reconstruction of abdominal wall using prosthetic material
10.8
8.3
15
14
N03AX16
ATC
pregabalin; oral
1.4
8.3
405
3024
Y83.8
ICD-10 Finland
Other surgical procedures as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
2.9
8.3
48
168
K52.9
ICD-10 Finland
Noninfective gastroenteritis and colitis, unspecified
2.3
8.2
75
338
TPH30
NOMESCO Finland
Insertion of central venous catheter through periferal vein
3.4
8.2
37
109
R2130
NOMESCO Finland
Counselling and guidance which enhance independent living
1.8
8.2
150
883
D50.8
ICD-10 Finland
Other iron deficiency anaemias
3.6
8.2
35
99
Z51.1
ICD-10 Finland
Chemotherapy session for neoplasm
3.3
8.1
39
121
8480/3-C18.4
ICD-O-3
Mucinous adenocarcinoma of transverse colon
33.5
8.1
10
*
C18.81
ICD-10 Finland
Malignant overall tumor of the colon invasive carcinoma
33.5
8.1
10
*
UJF12
NOMESCO Finland
Enteroscopy through intestinal stoma
17.2
8.1
12
7
D28
ICPC
Limited function/disability (D)
8.9
8.0
16
18
C77.2
ICD-10 Finland
Secondary and unspecified malignant neoplasm: Intra-abdominal lymph nodes
6.3
8.0
20
32
D37.9
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Digestive organ, unspecified
5.3
8.0
23
44
A28
ICPC
Limited function/disability NOS
1.5
8.0
342
2484
K59.1
ICD-10 Finland
Functional diarrhoea
2.0
8.0
99
509
SPAT1148
SPAT
Treatment of chronic ulcer or burn
1.5
8.0
284
1989
Z08.7
ICD-10 Finland
Follow-up examination after combined treatment for malignant neoplasm
4.2
7.9
28
67
133
Kela drug reimbursment
Severe chronic pancreatic insufficiency
3.5
7.9
35
102
JGB10
NOMESCO Finland
Partial proctectomy and end colostomy
13.1
7.9
13
10
JN4DD
NOMESCO Finland
Scout CT scan of torso
13.1
7.9
13
10
JFG20
NOMESCO Finland
Closure of enterostomy with resection of exteriorised loop
7.8
7.9
17
22
JAL00
NOMESCO Finland
Biopsy of peritoneum
6.1
7.8
20
33
Z01.8
ICD-10 Finland
Other specified special examinations
1.4
7.7
363
2687
K65.9
ICD-10 Finland
Peritonitis, unspecified
7.4
7.7
17
23
D48.49
ICD-10 Finland
Tumor of uncertain or unknown nature in the peritoneum, of unknown origin
18.4
7.6
11
6
SPAT1262
SPAT
Handing over of treatment supplies
1.4
7.6
346
2542
JGB06
NOMESCO Finland
Partial proctectomy with total excision of mesorectum
6.7
7.6
18
27
SPAT1254
SPAT
Administration of medicine
1.5
7.6
279
1967
Z71.3
ICD-10 Finland
Dietary counselling and surveillance
2.2
7.5
75
353
9680/3-C18.0
ICD-O-3
Diffuse large B-cell lymphoma, NOS, of cecum
80.4
7.4
8
*
JFB20
NOMESCO Finland
Ileocaecal resection
6.5
7.4
18
28
JJB50
NOMESCO Finland
Excision of segments V, VI, VII and VIII of liver
13.4
7.4
12
9
D62
ICD-10 Finland
Acute posthaemorrhagic anaemia
3.5
7.4
32
92
JAD10
NOMESCO Finland
Repair of incisional hernia
4.1
7.4
27
67
JN5ER
NOMESCO Finland
PET-CT of receptors in whole body
5.6
7.4
20
36
C18.70
ICD-10 Finland
Malignant tumor of the sigmoid without histology
3.4
7.3
33
98
Y83.6
ICD-10 Finland
Removal of other organ (partial) (total) as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
9.4
7.3
14
15
A06AC01
ATC
ispaghula (psylla seeds); oral
1.4
7.3
436
3367
ZXF00
NOMESCO Finland
Interruption caused by intraoperative deterioration of general condition
7.3
7.2
16
22
ZXE90
NOMESCO Finland
More than 22 hours
4.1
7.2
26
64
8140/3-C20.9
ICD-O-3
Adenocarcinoma, NOS, of rectum, NOS
2.5
7.2
51
204
K51.8
ICD-10 Finland
Other ulcerative colitis
3.8
7.2
28
74
C17.8
ICD-10 Finland
Malignant neoplasm: Overlapping lesion of small intestine
30.1
7.1
9
*
JFC20
NOMESCO Finland
Other enterocolostomy
20.1
7.1
10
5
8480/3-C18.9
ICD-O-3
Mucinous adenocarcinoma of colon, NOS
20.1
7.1
10
5
TK800
NOMESCO Finland
Hemodialysis
2.7
7.1
44
163
K56.1
ICD-10 Finland
Intussusception
6.0
7.1
18
30
N17.9
ICD-10 Finland
Acute renal failure, unspecified
2.0
7.1
88
455
UJK02
NOMESCO Finland
ERCP
2.3
7.0
59
256
D48.7
ICD-10 Finland
Neoplasm of uncertain or unknown behaviour: Other specified sites
4.7
7.0
22
47
Y83.2
ICD-10 Finland
Surgical operation with anastomosis, bypass or graft as the cause of abnormal reaction of the patient, or of later complication, without mention of misadventure at the time of the procedure
7.0
7.0
16
23
Z2221
NOMESCO Finland
Medical doctor
1.4
6.9
466
3662
XF400
NOMESCO Finland
ECG with 12 standard connections
1.4
6.9
324
2393
UJF92
NOMESCO Finland
Capsular endoscopy
2.9
6.9
38
131
B03XA02
ATC
darbepoetin alfa; parenteral
2.7
6.9
44
164
B82
ICPC
Anaemia other/unspecified
2.4
6.8
52
216
A02BC05
ATC
esomeprazole; systemic
1.3
6.8
695
5809
E86
ICD-10 Finland
Volume depletion
2.3
6.8
57
247
C57.0
ICD-10 Finland
Malignant neoplasm: Fallopian tube
9.3
6.8
13
14
8240/3-C18.2
ICD-O-3
Neuroendocrine tumor, NOS, of ascending colon
9.3
6.8
13
14
C18.80
ICD-10 Finland
Malignant overall tumor of the colon without histology
40.2
6.8
8
*
WF049
NOMESCO Finland
Radiotherapy of metastasis
2.1
6.6
69
333
JKE18
NOMESCO Finland
Endoscopic internal drainage of bile duct
4.0
6.6
24
60
K51.9
ICD-10 Finland
Ulcerative colitis, unspecified
2.5
6.6
50
207
XJA00
NOMESCO Finland
Intraoperative abdominal ultrasonography
12.3
6.6
11
9
L04AC05
ATC
ustekinumab; parenteral
10.0
6.5
12
12
E11.8
ICD-10 Finland
Type 2 diabetes mellitus, with unspecified complications
1.5
6.4
194
1308
K80.2
ICD-10 Finland
Calculus of gallbladder without cholecystitis
1.5
6.4
191
1283
8243/3-C18.1
ICD-O-3
Goblet cell carcinoid of appendix
70.0
6.4
7
*
JWE00
NOMESCO Finland
Reoperation for deep haemorrhage in gastroenterological surgery
7.4
6.4
14
19
K62.5
ICD-10 Finland
Haemorrhage of anus and rectum
1.9
6.4
93
511
Z76.9
ICD-10 Finland
Person encountering health services in unspecified circumstances
1.8
6.4
111
644
SPAT1251
SPAT
Organisation of medication
2.0
6.3
78
404
C18.60
ICD-10 Finland
Malignant tumor of the descending colon without histology
9.3
6.3
12
13
JN2AE
NOMESCO Finland
Ultrasound examination of lower part of abdomen without contrast
3.8
6.3
24
63
K91.3
ICD-10 Finland
Postoperative intestinal obstruction
18.1
6.3
9
5
JJA40
NOMESCO Finland
Excision of lesion of liver
+∞
6.3
6
*
WX730
NOMESCO Finland
Conventional respirator
2.8
6.2
37
134
JJB30
NOMESCO Finland
Excision of two segments of liver
26.7
6.2
8
*
A06AD11
ATC
lactulose; oral
1.4
6.2
303
2252
A87
ICPC
Complication of medical treatment
4.1
6.2
22
54
KA1AE
NOMESCO Finland
Kidney ultrasound examination
2.4
6.2
48
203
JN3DG
NOMESCO Finland
Very extensive MRI examination with high intensity magnet
6.3
6.2
15
24
138
Kela drug reimbursment
Severe anaemia associated with chronic renal failure
2.6
6.2
42
166
JEA01
NOMESCO Finland
Laparoscopic appendectomy
2.5
6.1
45
185
ZXE13
NOMESCO Finland
Procedure duration 90 to 119 minutes
2.4
6.1
47
196
RD210
NOMESCO Finland
NA
3.2
6.1
29
91
A41.8
ICD-10 Finland
Other specified sepsis
2.9
6.1
35
123
ZX121
NOMESCO Finland
Central venous catheter
8.6
6.1
12
14
PG1PT
NOMESCO Finland
Extensive endovascular embolisation for bleeding with radiological guidance not elsewhere classified
4.9
6.0
18
37
ZXE01
NOMESCO Finland
Procedure duration 0 to 9 minutes
3.0
6.0
31
103

LabWAS

↥
OMOP Concept
People with measurements
Mean N measurements
Mean measured value
(ID) Name
N Cases
N Controls
OR
-log10(p)
cases
controls
unit
cases
controls
-log10(p)
N cases
N controls
(3003785) Carcinoembryonic Ag [Mass/volume] in Serum or Plasma
1139
2036
10.57
307.65
7.6
3.8
ug/l
14.0
22.8
0.71
1029
1695
(3022914) Cancer Ag 19-9 [Units/volume] in Serum or Plasma
428
700
7.36
259.69
5.1
3.1
u/ml
482.1
5955.2
0.77
387
595
(3044640) Blood type and Crossmatch panel - Blood
1070
5732
2.69
111.00
4.2
2.5
—
—
—
0
0
(3013742) Prealbumin [Mass/volume] in Serum or Plasma
496
1774
3.32
108.28
2.8
2.1
g/l
0.2
0.2
1.11
476
1646
(3024561) Albumin [Mass/volume] in Serum or Plasma
1352
8193
2.70
108.15
11.7
4.6
g/l
32.2
34.7
37.70
1293
7572
(3022145) Colonoscopy Study observation
503
1839
3.25
105.66
1.5
1.3
—
—
—
0
0
(3006140) Bilirubin.total [Moles/volume] in Serum or Plasma
1486
9500
2.76
105.62
13.9
6.1
umol/l
12.5
12.1
0.42
1456
8999
(3051552) Clostridioides difficile toxin genes [Presence] in Stool by NAA with probe detection
432
1447
3.47
104.50
1.9
1.6
—
—
—
0
0
(3016771) Amylase [Enzymatic activity/volume] in Serum or Plasma
1023
5621
2.54
97.06
3.8
2.5
u/l
57.6
57.8
0.03
985
5164
(3023368) Bacteria identified in Blood by Culture
1020
5650
2.51
94.39
5.9
4.4
—
—
—
0
0
(3001079) Blood group antibody screen [Presence] in Serum or Plasma
1317
8201
2.52
94.33
6.6
4.2
—
—
—
0
0
(3005772) Bilirubin.conjugated [Moles/volume] in Serum or Plasma
501
1985
2.98
90.21
3.8
2.7
umol/l
9.9
9.5
0.12
453
1735
(46236098) ABO and Rh group [Type] in Blood by Confirmatory method
839
4412
2.46
84.84
3.9
2.4
—
—
—
0
0
(42529201) Cancer Ag 19-9 [Units/volume] in Serum or Plasma by Immunoassay
190
409
4.99
83.42
4.6
3.2
u/ml
148.2
1038.7
0.80
174
380
(4035726)
410
1548
3.03
79.66
1.4
1.4
—
—
—
0
0
(40762366) Oxygen capacity [Volume Fraction] in Arterial blood
308
1055
3.23
70.22
12.9
9.8
—
—
—
0
0
(3004789) Transferrin [Mass/volume] in Serum or Plasma
591
2854
2.47
69.79
2.9
2.5
g/l
2.4
2.3
3.76
559
2627
(3016417) Amylase.pancreatic [Enzymatic activity/volume] in Serum or Plasma
407
1640
2.82
69.49
3.5
2.4
u/l
42.5
40.2
0.12
372
1386
(3022948) Iron [Moles/volume] in Serum or Plasma
618
3089
2.39
67.25
3.0
2.5
umol/l
10.1
12.3
11.74
575
2848
(3042936) Bacteria identified in Isolate by Culture
558
2668
2.46
67.00
3.0
2.0
—
—
—
0
0
(3014576) Chloride [Moles/volume] in Serum or Plasma
526
2459
2.50
66.23
13.8
6.5
mmol/l
104.5
104.2
0.57
516
2392
(3015399) Transferrin receptor.soluble [Mass/volume] in Serum or Plasma
866
5019
2.20
65.87
2.9
2.2
mg/l
3.8
3.1
8.27
767
4232
(3020427) Coagulation factor X inhibitor [Units/volume] in Platelet poor plasma by Coagulation assay
241
740
3.54
65.26
3.2
2.6
u/ml
0.3
0.4
2.20
144
439
(40763571) Iron/Transferrin [Ratio] in Serum or Plasma
557
2697
2.43
64.77
3.0
2.5
%
17.2
22.0
14.81
467
2280
(3032080) INR in Blood by Coagulation assay
1212
8089
2.12
62.95
11.5
11.0
inr
1.3
1.3
1.57
254
2233
(3013650) Neutrophils [#/volume] in Blood by Automated count
1405
9929
2.16
62.61
16.9
8.7
e9/l
4.3
4.3
0.08
1262
8634
(3012095) Magnesium [Moles/volume] in Serum or Plasma
599
3082
2.30
59.98
5.5
3.0
mmol/l
0.8
0.8
4.57
577
2857
(3013721) Aspartate aminotransferase [Enzymatic activity/volume] in Serum or Plasma
881
5304
2.11
59.19
5.5
3.2
u/l
42.5
33.7
1.02
846
5022
(3020779) Urea [Moles/volume] in Serum or Plasma
411
1808
2.57
58.15
8.4
6.5
mmol/l
9.9
10.9
1.71
398
1706
(3016502) Oxygen saturation in Arterial blood
448
2076
2.46
56.59
11.8
7.2
%
96.2
95.2
2.51
429
1992
(3002173) Hemoglobin [Mass/volume] in Arterial blood
420
1891
2.51
56.45
12.5
7.7
g/l
111.6
120.5
15.36
406
1817
(3027946) Carbon dioxide [Partial pressure] in Arterial blood
482
2320
2.38
55.87
11.3
6.9
kpa
5.1
5.1
0.42
458
2200
(3027801) Oxygen [Partial pressure] in Arterial blood
482
2321
2.38
55.81
11.3
6.9
kpa
13.9
11.7
12.56
458
2202
(3003396) Base excess in Arterial blood by calculation
481
2324
2.37
55.21
11.3
6.9
mmol/l
0.6
1.2
2.47
380
1788
(3033658) Prothrombin time (PT) actual/Normal
766
4535
2.06
52.40
7.9
4.0
%
85.2
85.5
0.15
757
4418
(3016431) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Serum or Plasma
1320
9489
1.98
51.32
10.9
6.7
mmol/l
1.2
1.2
15.51
1156
7921
(3014111) Lactate [Moles/volume] in Serum or Plasma
380
1733
2.44
49.14
9.5
6.3
mmol/l
1.4
1.4
0.14
367
1668
(3003458) Phosphate [Moles/volume] in Serum or Plasma
501
2576
2.23
48.99
7.2
5.3
mmol/l
1.0
1.0
0.30
477
2364
(3035995) Alkaline phosphatase [Enzymatic activity/volume] in Serum or Plasma
1705
13652
2.12
46.15
16.5
7.6
u/l
92.5
80.9
6.42
1655
12767
(3021347) Calcium.ionized [Moles/volume] in Serum or Plasma
1210
8629
1.90
46.06
10.1
5.9
mmol/l
1.2
1.2
12.70
1128
7733
(40768804) Tissue Pathology biopsy report
1007
6821
1.88
44.48
2.8
2.2
—
—
—
0
0
(3016407) Fibrinogen [Mass/volume] in Platelet poor plasma by Coagulation assay
159
480
3.49
43.83
2.9
2.3
g/l
3.6
3.6
0.01
151
452
(3037121) Protein [Mass/volume] in Urine
193
667
3.08
42.65
5.0
3.0
g/l
0.2
0.3
1.24
138
247
(3000991) Gas panel - Venous blood
347
1635
2.33
41.19
11.8
7.5
—
—
—
0
0
(3001122) Ferritin [Mass/volume] in Serum or Plasma
1019
7070
1.83
40.43
3.9
2.8
ug/l
135.5
146.2
0.39
954
6404
(3013826) Glucose [Moles/volume] in Serum or Plasma
1405
10757
1.85
40.20
8.8
4.8
mmol/l
6.9
6.9
0.38
1362
10129
(3037551) Cancer Ag 125 [Units/volume] in Serum or Plasma
202
742
2.90
39.99
6.6
3.7
u/ml
104.1
74.6
0.42
197
711
(42870588) Differential panel, method unspecified - Blood
888
6004
1.81
37.58
7.2
5.6
—
—
—
0
0
(3027945) Reticulocytes/100 erythrocytes in Blood
454
2463
2.06
37.56
2.4
2.5
%
1.8
1.8
0.06
408
2163
(3002030) Lymphocytes/100 leukocytes in Blood
1125
8184
1.77
36.82
8.0
5.9
%
24.0
26.4
9.14
1054
7570
(3006504) Eosinophils/100 leukocytes in Blood
1104
8011
1.76
36.24
7.8
5.8
%
2.6
2.8
3.08
1034
7419
(3019069) Monocytes/100 leukocytes in Blood
1107
8039
1.76
36.24
8.2
6.0
%
8.9
8.9
0.31
1038
7475
(3022096) Basophils/100 leukocytes in Blood
1075
7803
1.74
34.71
7.8
5.8
%
0.6
0.7
3.00
1009
7236
(3006315) Basophils [#/volume] in Blood
1150
8510
1.74
34.62
7.5
5.5
e9/l
0.0
0.0
0.64
998
7274
(3018010) Neutrophils/100 leukocytes in Blood
1100
8043
1.74
34.54
7.8
5.7
%
60.4
58.3
6.02
1034
7471
(3001604) Monocytes [#/volume] in Blood
1146
8479
1.74
34.46
7.5
5.5
e9/l
0.6
0.6
0.96
993
7231
(3013115) Eosinophils [#/volume] in Blood
1172
8796
1.72
32.84
8.0
5.7
e9/l
0.2
0.2
1.54
1023
7638
(3008909) Norovirus RNA [Presence] in Stool by NAA with probe detection
169
632
2.81
32.24
1.4
1.2
—
—
—
0
0
(3018572) Chloride [Moles/volume] in Blood
137
461
3.10
31.57
9.5
7.6
mmol/l
106.0
105.4
0.69
125
412
(3039000) Anion gap in Blood
137
461
3.10
31.57
9.4
7.5
mmol/l
11.4
11.1
0.46
125
412
(3007930) Methemoglobin/Hemoglobin.total in Blood
202
836
2.56
31.54
7.7
5.6
%
0.9
0.9
0.63
189
784
(3014007) Fractional oxyhemoglobin in Arterial blood
264
1239
2.29
31.18
14.8
8.4
%
94.5
93.7
1.72
264
1231
(3019198) Lymphocytes [#/volume] in Blood
1152
8682
1.69
31.11
7.6
5.6
e9/l
1.8
1.9
0.21
1014
7562
(3005715) Vancomycin [Mass/volume] in Serum or Plasma
95
255
3.85
31.10
9.4
6.6
mg/l
13.4
12.4
0.97
85
233
(3023520) Reticulocytes [#/volume] in Blood
350
1843
2.07
30.88
2.4
2.5
e9/l
68.5
69.1
0.12
264
1432
(3014218) Bicarbonate [Moles/volume] standard in Arterial blood
233
1053
2.36
30.00
13.3
8.6
mmol/l
23.8
24.4
1.83
226
978
(3023081) Carboxyhemoglobin/Hemoglobin.total in Blood
200
845
2.50
29.86
7.8
5.6
%
1.6
1.6
0.02
187
792
(3022250) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma by Lactate to pyruvate reaction
409
2315
1.94
29.30
4.0
3.9
u/l
238.8
250.0
0.75
391
2174
(3047181) Lactate [Moles/volume] in Blood
163
629
2.72
29.25
8.7
6.7
mmol/l
1.4
1.3
0.80
145
549
(3036489) Thrombin time
160
618
2.71
28.66
2.7
2.0
s
21.9
21.6
0.21
154
557
(3002032) Base excess in Venous blood by calculation
349
1894
2.00
28.15
4.7
3.5
mmol/l
1.9
1.9
0.02
279
1504
(3026782) Osmolality of Urine
594
3840
1.75
27.47
3.8
2.8
mosm/kgh2o
552.8
552.5
0.01
532
3276
(3021447) Carbon dioxide [Partial pressure] in Venous blood
347
1899
1.98
27.27
4.7
3.5
kpa
5.7
5.8
2.52
340
1838
(40758558) Short blood count panel - Blood
650
4362
1.70
26.01
13.8
6.5
—
—
—
0
0
(3002582) Erythrocytes [#/volume] in Urine
806
5750
1.64
25.29
4.1
3.4
e6/l
32.1
83.6
3.60
675
4507
(3019060) Gas panel - Arterial blood
270
1399
2.06
24.58
8.5
4.8
—
—
—
0
0
(3018677) aPTT in Platelet poor plasma by Coagulation assay
468
2972
1.73
22.44
2.6
2.0
s
30.1
30.1
0.03
458
2871
(3008152) Bicarbonate [Moles/volume] in Arterial blood
248
1291
2.04
22.21
12.4
7.0
mmol/l
24.1
24.6
0.92
230
1198
(3000570) Elastase.pancreatic [Mass/mass] in Stool
131
524
2.60
21.85
1.5
1.5
ug/g
237.0
277.2
1.37
87
310
(3026910) Gamma glutamyl transferase [Enzymatic activity/volume] in Serum or Plasma
1260
10250
1.54
20.94
4.8
3.2
u/l
74.2
54.8
4.71
1192
9371
(43055120) Cytomegalovirus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
94
323
3.00
20.90
9.3
5.3
iu/ml
713.2
833.3
0.07
19
47
(3031040) Bacteria [#/volume] in Urine by Automated count
1420
11896
1.55
20.34
5.6
5.0
e6/l
593.0
1959.3
1.24
20
200
(3015377) Calcium [Moles/volume] in Serum or Plasma
850
6405
1.53
19.77
7.0
3.3
mmol/l
2.3
2.4
2.77
774
5491
(3044938) Influenza virus A RNA [Presence] in Specimen by NAA with probe detection
510
3440
1.63
19.06
2.0
1.9
—
—
—
0
0
(3026008) Bacteria identified in Urine by Culture
807
6059
1.53
18.85
4.0
3.4
—
—
—
0
0
(3048689) Calprotectin [Mass/mass] in Stool
289
1673
1.84
18.74
3.6
2.1
ug/g
171.0
145.3
0.73
238
1315
(3012336) Haptoglobin [Mass/volume] in Serum or Plasma
198
1009
2.06
18.71
1.7
1.7
g/l
1.7
1.5
1.79
173
873
(3018095) Leukocytes [#/volume] in Urine
859
6548
1.51
18.61
4.8
3.9
e6/l
135.6
124.7
0.07
695
4805
(3030467) Casts [#/volume] in Urine by Automated count
716
5260
1.54
18.40
4.2
3.3
e6/l
0.4
0.5
0.59
595
4053
(3029879) Epithelial cells.squamous [#/volume] in Urine by Automated count
456
3038
1.63
17.76
3.6
3.1
e6/l
2.1
2.2
0.07
286
1696
(3024354) Oxygen [Partial pressure] in Venous blood
270
1555
1.84
17.76
4.1
2.8
kpa
4.8
4.5
0.97
263
1499
(43054903) Holo-transcobalamin II [Moles/volume] in Serum
1009
8019
1.48
17.46
2.4
2.1
pmol/l
87.1
92.8
3.54
632
4121
(3007628) Bicarbonate [Moles/volume] standard in Venous blood
182
930
2.04
17.05
4.6
3.6
mmol/l
23.5
24.1
1.31
177
839
(3018418) pH of Serum or Plasma
756
5695
1.50
16.93
5.6
4.0
ph
7.4
7.4
0.36
131
1095
(3046279) Procalcitonin [Mass/volume] in Serum or Plasma
175
884
2.06
16.92
2.3
1.8
ug/l
1.6
2.2
0.41
158
759
(3000850) Epithelial cells [#/volume] in Urine
574
4082
1.55
16.82
3.1
2.7
e6/l
5.4
5.2
0.11
526
3609
(36304419) Bacteria [Presence] in Urine
684
5072
1.51
16.43
4.1
3.3
—
—
—
0
0
(3025941) Bacteria identified in Stool by Culture
166
841
2.05
15.92
1.3
1.3
—
—
—
0
0
(4281824)
57
177
3.28
15.08
1.3
1.2
—
—
—
0
0
(40768797) Stomach Pathology biopsy report
372
2446
1.63
15.05
1.3
1.2
—
—
—
0
0
(3002256) Pathology report gross observation
347
2249
1.65
14.86
1.4
1.4
—
—
—
0
0
(3037467) Urinalysis macro (dipstick) panel - Urine
1406
12137
1.44
14.47
6.1
4.6
—
—
—
0
0
(3016251) Hemoglobin.gastrointestinal [Presence] in Stool
190
1046
1.89
14.33
2.6
2.5
—
—
—
0
0
(586526) SARS-CoV-2 (COVID-19) RNA [Presence] in Nasopharynx by NAA with probe detection
211
1203
1.83
14.26
1.6
1.5
—
—
—
0
0
(37020445) Astrovirus RNA [Presence] in Stool by NAA with probe detection
37
89
4.21
14.15
1.4
1.3
—
—
—
0
0
(37021247) Adenovirus 40+41 DNA [Presence] in Stool by NAA with probe detection
37
89
4.21
14.15
1.4
1.3
—
—
—
0
0
(3019309) Folate [Moles/volume] in Red Blood Cells
563
4114
1.50
14.14
1.9
1.8
nmol/l
1087.9
1171.1
1.44
448
3042
(3007853) Bacteria identified in Skin by Aerobe culture
330
2144
1.63
13.94
2.2
1.8
—
—
—
0
0
(3030306) Epithelial cells.non-squamous [#/volume] in Urine by Automated count
460
3237
1.53
13.78
3.5
2.9
e6/l
0.9
1.3
2.16
293
1886
(3004119) Hemoglobin [Mass/volume] in Venous blood
215
1248
1.80
13.69
4.2
3.0
g/l
118.2
127.0
6.47
210
1214
(3019284) Hepatitis B virus surface Ag [Presence] in Serum
248
1508
1.73
13.44
1.5
1.5
—
—
—
0
0
(37019628) Gastrointestinal bacterial pathogens panel - Stool by NAA with probe detection
90
382
2.41
13.31
1.6
1.3
—
—
—
0
0
(3017143) Hepatitis C virus Ab [Presence] in Serum
233
1401
1.74
13.14
1.5
1.5
—
—
—
0
0
(3009306) Alpha-1-Fetoprotein [Mass/volume] in Serum or Plasma
24
43
5.63
12.89
1.8
2.8
—
—
—
0
0
(37020957) Sapovirus genogroups I+II+IV+V RNA [Presence] in Stool by NAA with probe detection
43
124
3.52
12.80
1.4
1.3
—
—
—
0
0
(42869457) Rotavirus RNA [Identifier] in Stool by NAA with probe detection
43
125
3.49
12.65
1.4
1.3
—
—
—
0
0
(21493466) Plesiomonas shigelloides DNA [Presence] in Stool by NAA with non-probe detection
62
227
2.78
12.39
1.5
1.3
—
—
—
0
0
(40761516) BRAF gene p.Val600Glu [Presence] in Tissue by Molecular genetics method
14
14
10.06
12.24
1.0
1.0
—
—
—
0
0
(3005988) Vibrio sp identified in Specimen by Organism specific culture
62
229
2.76
12.19
1.5
1.3
—
—
—
0
0
(3000494) Fungus identified in Specimen by Culture
304
2005
1.60
11.98
1.8
1.4
—
—
—
0
0
(3012568) Campylobacter sp identified in Specimen by Organism specific culture
62
232
2.72
11.90
1.5
1.3
—
—
—
0
0
(3003694) ABO and Rh group [Type] in Blood
559
4199
1.44
11.87
1.4
1.3
—
—
—
0
0
(3025468) Yersinia sp identified in Specimen by Organism specific culture
61
227
2.74
11.83
1.5
1.4
—
—
—
0
0
(3051714) Fibrin D-dimer FEU [Mass/volume] in Platelet poor plasma
502
3703
1.46
11.71
2.4
1.7
mg/l
2.2
1.4
2.85
415
2881
(3021337) Troponin I.cardiac [Mass/volume] in Serum or Plasma
515
3836
1.45
11.38
4.2
4.1
ng/l
410.7
372.9
0.08
430
3250
(3021960) Folate [Moles/volume] in Serum or Plasma
618
4764
1.41
11.28
1.8
1.6
nmol/l
19.8
20.3
0.31
559
4011
(3021197) Magnesium Ionized [Moles/volume] in Serum or Plasma
27
61
4.47
11.20
2.2
2.6
—
—
—
0
0
(36305247) Microscopic observation [Identifier] in Isolate by Gram stain
110
554
2.04
10.76
2.5
1.7
—
—
—
0
0
(3020059) Calcium [Moles/volume] corrected for albumin in Serum or Plasma
500
3741
1.44
10.70
7.2
3.0
mmol/l
2.5
2.5
1.21
457
3284
(42868716) Shigella species+EIEC invasion plasmid antigen H ipaH gene [Presence] in Stool by NAA with probe detection
59
230
2.61
10.49
1.6
1.3
—
—
—
0
0
(3024522) Salmonella sp identified in Specimen by Organism specific culture
59
231
2.60
10.40
1.6
1.3
—
—
—
0
0
(3020460) C reactive protein [Mass/volume] in Serum or Plasma
1808
16748
1.46
9.88
34.9
16.7
mg/l
39.6
26.5
34.59
1685
13638
(3024403) Complement+Immunoglobulin [Units/volume] in Red Blood Cells
103
525
2.01
9.77
1.7
1.5
—
—
—
0
0
(3011960) Natriuretic peptide B [Mass/volume] in Serum or Plasma
280
1906
1.54
9.53
3.8
3.1
ng/l
242.3
245.9
0.04
252
1740
(3019601) Blood group antibody investigation [Interpretation] in Plasma or RBC
34
105
3.27
9.18
2.5
1.8
—
—
—
0
0
(3043924) Respiratory syncytial virus RNA [Identifier] in Specimen by NAA with probe detection
338
2413
1.47
9.14
1.9
1.8
—
—
—
0
0
(3007566) Smooth muscle Ab [Titer] in Serum
87
429
2.07
9.05
1.3
1.2
titre
78.8
86.8
—
8
31
(3023183) Ammonium ion [Moles/volume] in Plasma
84
416
2.06
8.65
2.5
2.8
umol/l
35.0
35.3
0.03
75
338
(3038288) Influenza virus B RNA [Presence] in Specimen by NAA with probe detection
333
2404
1.45
8.47
2.0
1.8
—
—
—
0
0
(46235759) Influenza virus B RNA [Presence] in Nasopharynx by NAA with probe detection
144
859
1.72
8.36
2.1
1.9
—
—
—
0
0
(40768441) Liver Pathology biopsy report
35
118
3.00
8.20
1.2
1.3
—
—
—
0
0
(3004809) Band form neutrophils/100 leukocytes in Blood
69
327
2.15
7.99
2.7
3.7
%
2.6
1.4
0.92
54
251
(3003181) Sodium [Moles/volume] in Urine
74
365
2.06
7.74
1.7
1.3
mmol/l
51.7
60.4
1.28
54
297
(3033705) Calcium.ionized [Moles/volume] in Venous blood
61
280
2.21
7.66
3.5
2.4
—
—
—
0
0
(3043405) Microscopic observation [Identifier] in Specimen by Non-gynecological cytology method
42
163
2.61
7.62
1.2
1.3
—
—
—
0
0
(3019225) pH of Specimen
276
1961
1.47
7.59
6.2
4.4
—
—
—
0
0
(3052851) Hemolysis interference index of Serum or Plasma
105
588
1.83
7.58
5.1
3.6
—
—
—
0
0
(1761482) Bacteria [#/volume] in Urine by Culture
100
554
1.84
7.48
7.2
4.6
—
—
—
0
0
(40762365) Oxygen content in Arterial blood by calculation
18
41
4.42
7.43
3.3
3.3
ml/dl
13.6
15.3
1.18
18
36
(3019800) Troponin T.cardiac [Mass/volume] in Serum or Plasma
874
7454
1.29
7.38
4.8
4.1
ng/l
42.4
55.4
0.82
719
5647
(3041354) Potassium [Moles/volume] in Venous blood
61
285
2.17
7.35
3.5
2.4
mmol/l
4.0
4.1
0.91
61
280
(3035285) Chloride [Moles/volume] in Venous blood
61
285
2.17
7.35
3.5
2.4
mmol/l
104.7
105.5
0.46
61
280
(3013707) Erythrocyte sedimentation rate by Westergren method
1409
12774
1.29
7.24
4.6
4.2
mm/h
18.0
14.0
12.42
1294
11719
(3044254) Respiratory syncytial virus RNA [Presence] in Specimen by NAA with probe detection
129
786
1.68
6.97
2.0
1.8
—
—
—
0
0
(3045781) Inhibin B [Mass/volume] in Serum or Plasma
12
20
6.03
6.90
4.4
2.1
ng/l
123.0
66.7
—
5
8
(3043362) Influenza virus B Ag [Presence] in Nasopharynx by Immunoassay
85
466
1.86
6.60
1.5
1.4
—
—
—
0
0
(3046524) Influenza virus A Ag [Presence] in Nasopharynx by Immunoassay
85
466
1.86
6.60
1.5
1.4
—
—
—
0
0
(3029187) Natriuretic peptide.B prohormone N-Terminal [Mass/volume] in Serum or Plasma
746
6328
1.27
6.33
3.5
3.1
ng/l
1902.7
1770.3
0.23
661
5458
(1175553) Vedolizumab and Vedolizumab Ab panel [Mass/volume] - Serum or Plasma
9
5
18.07
6.26
2.0
1.8
—
—
—
0
0
(3021589) Normoblasts [#/volume] in Blood
861
7462
1.25
6.01
16.5
10.2
e9/l
0.0
0.0
0.48
700
6061
(3017181) Myelocytes/100 leukocytes in Blood
212
1498
1.46
6.00
4.2
4.1
%
1.0
0.8
0.57
89
456
(36031861) Influenza virus A and B and SARS-CoV-2 (COVID-19) and Respiratory syncytial virus RNA panel - Respiratory system specimen by NAA with probe detection
193
1342
1.48
5.93
1.8
1.7
—
—
—
0
0
(36305075) Vedolizumab [Mass/volume] in Serum or Plasma by Immunoassay
9
6
15.05
5.90
2.0
1.8
mg/l
18.6
18.8
—
9
6
(3003434) Protein [Mass/volume] in Pleural fluid
61
313
1.98
5.81
1.3
1.5
g/l
28.0
31.5
1.15
54
285
(3048929) Epstein Barr virus Ab [Presence] in Serum
65
341
1.93
5.81
1.3
1.2
—
—
—
0
0
(3009343) pH of Capillary blood
183
1266
1.49
5.77
4.4
3.7
ph
7.4
7.4
0.28
25
160
(3022493) Free Hemoglobin [Mass/volume] in Plasma
22
70
3.16
5.74
5.0
3.7
mg/l
54.1
64.5
0.57
15
51
(3051651) Icteric interference index of Serum or Plasma
30
114
2.65
5.74
7.5
3.6
—
—
—
0
0
(46235355) HIV 1 and 2 tests - Meaningful Use set
242
1768
1.41
5.72
1.7
1.6
—
—
—
0
0
(3018171) Choriogonadotropin [Units/volume] in Serum or Plasma
34
138
2.49
5.70
1.2
2.0
u/l
161.4
2706.5
—
8
53
(3023024) Carbon dioxide [Partial pressure] in Capillary blood
185
1286
1.48
5.70
4.5
3.7
kpa
5.1
5.2
0.96
171
1178
(43055554) Base excess.100% oxygenated [Moles/volume] standard in Capillary blood by calculation
176
1214
1.49
5.63
4.5
3.7
mmol/l
1.5
1.9
0.57
126
894
(3005719) IgG [Mass/volume] in Serum or Plasma
179
1240
1.48
5.61
2.7
2.7
g/l
10.8
10.7
0.08
166
1119
(3003031) Transferrin.carbohydrate deficient.disialo/Transferrin.total in Serum or Plasma
212
1520
1.44
5.56
1.8
1.7
%
1.6
1.6
0.13
178
1272
(3022217) INR in Platelet poor plasma by Coagulation assay
364
2852
1.33
5.56
24.0
28.8
inr
1.3
1.5
0.89
59
372
(3007844) Epstein Barr virus capsid IgM Ab [Units/volume] in Serum by Immunoassay
52
257
2.05
5.50
1.3
1.2
—
—
—
0
0
(3009035) Cobalamin (Vitamin B12) [Moles/volume] in Serum or Plasma
514
4230
1.28
5.45
1.9
1.7
pmol/l
22222625.8
23622473.7
0.02
441
3429
(1761868) Lipid panel - Serum or Plasma
401
4959
0.77
5.42
3.1
3.1
—
—
—
0
0
(3006922) Hepatitis E virus Ab [Presence] in Serum
24
84
2.88
5.35
1.2
1.1
—
—
—
0
0
(3038515) Glucose [Moles/volume] in Venous blood
79
454
1.77
5.33
5.5
3.4
mmol/l
7.5
7.8
0.62
79
441
(3028026) IgM [Mass/volume] in Serum or Plasma
147
992
1.52
5.24
2.0
1.8
g/l
1.1
1.5
3.20
134
894
(3021879) Hepatitis B virus core Ab [Presence] in Serum
135
895
1.54
5.22
1.3
1.4
—
—
—
0
0
(3021440) Promyelocytes/100 leukocytes in Blood
197
1412
1.43
5.19
4.3
4.1
%
0.1
0.1
0.10
84
418
(3009261) Glucose [Presence] in Urine by Test strip
965
8569
1.23
5.13
4.8
4.0
estimate
0.0
0.0
0.80
169
1554
(40760892) CBC W Ordered Manual Differential panel - Blood
426
3447
1.29
5.12
5.6
4.5
—
—
—
0
0
(3005757) Coagulation factor V activity actual/normal in Platelet poor plasma by Coagulation assay
22
76
2.91
5.03
2.5
2.3
%
94.6
96.1
0.08
22
71
(3019900) Cholesterol [Moles/volume] in Serum or Plasma
1530
16260
0.80
5.02
4.3
4.7
mmol/l
4.4
4.5
5.34
1381
14747
(3002222) Hepatitis E virus IgM Ab [Presence] in Serum
23
82
2.82
4.98
1.1
1.0
—
—
—
0
0
(3029023) Hepatitis E virus IgG Ab [Presence] in Serum by Immunoassay
23
82
2.82
4.98
1.1
1.0
—
—
—
0
0
(3024928) Oxygen saturation in Venous blood
73
419
1.77
4.97
3.0
2.5
—
—
—
0
0
(46237023) Hepatitis B virus core and surface Ab and surface Ag panel - Serum
65
361
1.83
4.93
1.4
1.3
—
—
—
0
0
(3002179) Metamyelocytes/100 leukocytes in Blood
188
1350
1.43
4.91
4.0
3.9
%
1.2
0.6
1.13
60
325
(3024891) Influenza virus A+B Ag [Presence] in Specimen
73
422
1.76
4.85
1.3
1.2
—
—
—
0
0
(3023602) Cholesterol in HDL [Moles/volume] in Serum or Plasma
1514
16090
0.81
4.84
4.3
4.6
mmol/l
1.4
1.4
1.53
1353
14466
(3033799) Differential panel - Peritoneal fluid
18
57
3.18
4.76
2.3
2.2
—
—
—
0
0
(3014765) Yersinia sp identified in Stool by Organism specific culture
81
487
1.69
4.70
1.2
1.1
—
—
—
0
0
(3016038) Potassium [Moles/volume] in Urine
31
133
2.35
4.67
1.5
1.2
mmol/l
38.2
35.8
0.21
31
116
(3000330) Specific gravity of Urine by Test strip
148
1028
1.47
4.62
6.4
3.6
—
—
—
0
0
(3052592) Norovirus Ag [Presence] in Stool
15
43
3.51
4.61
1.2
1.4
—
—
—
0
0
(3007080) Epstein Barr virus nuclear IgG Ab [Units/volume] in Serum
47
240
1.98
4.60
1.3
1.2
u/ml
398.9
286.5
1.11
36
137
(3015235) Bicarbonate [Moles/volume] in Capillary blood
87
538
1.64
4.54
3.6
3.2
mmol/l
24.0
25.1
1.04
74
462
(3015736) pH of Urine
758
6633
1.22
4.50
4.5
3.7
—
6.0
—
0
5
(3023487) Leukocytes [#/volume] in Peritoneal fluid
20
70
2.87
4.49
2.0
2.4
e6/l
6098.0
757.6
0.48
15
58
(3017354) Segmented neutrophils/100 leukocytes in Blood
42
208
2.04
4.48
3.0
3.5
%
62.7
55.2
1.00
25
138
(3001308) Cholesterol in LDL [Moles/volume] in Serum or Plasma
1583
16700
0.81
4.42
4.8
5.3
mmol/l
2.5
2.6
7.47
1412
15059
(3006418) Campylobacter sp identified in Tissue by Organism specific culture
79
481
1.67
4.39
1.2
1.2
—
—
—
0
0
(3021601) Nitrite [Presence] in Urine by Test strip
946
8472
1.21
4.39
6.8
5.3
estimate
0.0
0.0
0.42
171
1592
(3019050) Tissue transglutaminase IgA Ab [Units/volume] in Serum
391
3189
1.28
4.38
1.3
1.2
u/ml
1.5
1.5
0.03
88
796
(3006270) Folate [Moles/volume] in Blood
35
163
2.17
4.38
1.3
1.2
nmol/l
321.4
345.7
0.21
26
135
(3013327) Hepatitis A virus IgM Ab [Presence] in Serum
46
238
1.95
4.36
1.1
1.1
—
—
—
0
0
(42529406) Shigella sp [Presence] in Stool by Culture
80
490
1.66
4.35
1.2
1.2
—
—
—
0
0
(3005785) Creatine kinase.MB [Mass/volume] in Serum or Plasma
244
1875
1.34
4.24
2.4
2.5
ug/l
7.0
6.8
0.04
213
1612
(3043410) Blood group antigens tested for on Red Blood Cells
17
56
3.05
4.24
1.8
2.2
—
—
—
0
0
(3009595) Pneumocystis jiroveci DNA [Presence] in Specimen by NAA with probe detection
32
148
2.18
4.09
1.5
1.7
—
—
—
0
0
(3023199) Leukocytes [#/volume] in Pleural fluid
52
287
1.83
4.08
1.3
1.4
e6/l
900.6
1632.5
1.21
39
210
(3013512) EKG study
647
5623
1.21
4.03
5.1
4.3
—
—
—
0
0
(3017918) Cytomegalovirus IgG Ab [Titer] in Serum or Plasma
51
281
1.83
4.03
1.4
1.4
—
—
—
0
0
(3032352) Blasts [#/volume] in Cerebral spinal fluid
9
14
6.45
3.98
2.1
2.7
—
—
—
0
0
(3021901) Oxygen saturation in Capillary blood
66
394
1.70
3.98
3.5
2.9
—
—
—
0
0
(3023601) Vancomycin resistant enterococcus [Presence] in Specimen by Organism specific culture
41
212
1.95
3.92
4.3
2.5
—
—
—
0
0
(3028626) Oxygen [Partial pressure] in Capillary blood
75
465
1.63
3.92
3.5
3.0
kpa
7.8
7.8
0.09
70
424
(3035350) Ketones [Presence] in Urine by Test strip
939
8469
1.19
3.88
4.7
4.0
estimate
0.0
0.0
0.00
169
1592
(40763082) Lactate dehydrogenase [Enzymatic activity/volume] in Pleural fluid by Lactate to pyruvate reaction
41
213
1.94
3.87
1.2
1.3
u/l
247.5
330.3
0.97
36
207
(3012441) Differential panel - Pleural fluid
45
242
1.88
3.84
1.3
1.5
—
—
—
0
0
(3028308) Erythrocytes [#/volume] in Pleural fluid
47
257
1.85
3.82
1.3
1.4
e6/l
72005.9
76740.4
0.03
27
158
(3020891) Body temperature
117
811
1.47
3.74
9.1
4.3
—
—
—
0
0
(3044007) Cell count panel - Peritoneal fluid
16
55
2.92
3.73
1.8
2.2
—
—
—
0
0
(3020630) Protein [Mass/volume] in Serum or Plasma
225
1743
1.32
3.72
2.7
2.7
g/l
65.0
66.2
1.39
209
1585
(3000067) Parathyrin.intact [Mass/volume] in Serum or Plasma
201
1532
1.34
3.71
5.0
3.7
ng/l
112.5
97.4
1.09
174
1304
(3025159) Blasts/100 leukocytes in Blood
176
1315
1.37
3.69
4.3
4.2
%
0.1
0.3
0.52
66
350
(3019550) Sodium [Moles/volume] in Serum or Plasma
1834
17618
1.25
3.67
39.9
19.8
mmol/l
139.0
139.6
18.50
1812
17135
(3013566) Clostridioides difficile [Presence] in Stool by Organism specific culture
20
79
2.55
3.63
1.1
1.3
—
—
—
0
0
(3048773) Triglyceride [Moles/volume] in Serum or Plasma --fasting
1475
15574
0.84
3.61
4.1
4.1
mmol/l
1.4
1.3
6.97
1315
13874
(3026250) Tacrolimus [Mass/volume] in Blood
16
57
2.82
3.52
35.7
31.7
ug/l
6.9
6.8
0.01
16
50
(3036481) Cortisol [Moles/volume] in Serum or Plasma
198
1521
1.33
3.48
2.3
2.1
nmol/l
396.3
367.6
1.17
186
1373
(3009542) Hematocrit [Volume Fraction] of Blood
1545
14617
1.19
3.48
38.1
18.2
%
35.7
38.8
19.66
946
9332
(3023103) Potassium [Moles/volume] in Serum or Plasma
1835
17655
1.24
3.45
39.9
20.0
mmol/l
4.0
4.0
4.03
1811
17139
(3010130) Cytomegalovirus IgG Ab [Units/volume] in Serum or Plasma
44
244
1.82
3.45
1.5
1.4
u/ml
114.3
128.3
—
10
48
(3015635) Cytomegalovirus IgM Ab [Units/volume] in Serum or Plasma
50
289
1.75
3.42
1.4
1.3
—
16.5
—
0
7
(3007164) IgA [Mass/volume] in Serum or Plasma
344
2844
1.25
3.42
1.7
1.5
g/l
2.7
2.6
0.40
203
1647
(3028369) Herpes simplex virus 1+2 DNA [Presence] in Specimen by NAA with probe detection
28
133
2.12
3.40
1.1
1.3
—
—
—
0
0
(3008757) Leukocyte morphology finding [Identifier] in Blood
42
231
1.83
3.38
2.8
4.2
—
—
—
0
0
(3020393) Adenovirus Ag [Presence] in Stool
7
10
7.02
3.36
1.0
1.0
—
—
—
0
0
(3042733) HLA Ab [Presence] in Serum
12
37
3.26
3.34
6.3
4.4
—
—
—
0
0
(40771025) 25-Hydroxyvitamin D3+25-Hydroxyvitamin D2 [Moles/volume] in Serum or Plasma
797
7156
1.18
3.34
2.8
2.2
nmol/l
75.1
78.7
2.88
728
6234
(3043453) Neutrophil cytoplasmic Ab.perinuclear [Titer] in Serum
26
122
2.14
3.26
1.2
1.1
titre
350.0
135.9
—
5
22
(3014162) Mycobacterium tuberculosis DNA [Presence] in Specimen by NAA with probe detection
103
720
1.45
3.20
3.2
2.7
—
—
—
0
0
(3010144) Erythrocytes [#/volume] in Synovial fluid
33
172
1.93
3.14
1.2
1.3
e6/l
99334.5
120225.8
0.10
20
116
(3041942) Cyclic citrullinated peptide Ab [Units/volume] in Serum
197
2486
0.77
3.02
1.2
1.2
u/ml
12.4
12.8
0.03
80
896
(3000093) Morphology [Interpretation] in Blood Narrative
33
175
1.90
3.00
1.2
1.2
—
—
—
0
0
(3005702) Mycobacterium sp identified in Specimen by Organism specific culture
67
435
1.56
2.97
1.7
1.4
—
—
—
0
0
(40760109) Toxoplasma gondii IgG Ab avidity [Ratio] in Serum by Immunoassay
10
30
3.34
2.90
1.0
1.1
—
—
—
0
0
(3025839) Triglyceride [Moles/volume] in Serum or Plasma
379
4426
0.83
2.88
1.6
1.6
mmol/l
1.4
1.4
0.88
326
3658
(3028167) CD3+CD4+ (T4 helper) cells [#/volume] in Blood
22
102
2.17
2.87
1.2
2.0
e6/l
330.7
736.5
—
10
48
(3022313) Gas panel - Capillary blood
125
924
1.37
2.86
5.0
3.8
—
—
—
0
0
(3017732) Neutrophils [#/volume] in Blood
146
1109
1.34
2.81
3.7
3.1
e9/l
3.8
4.2
1.81
111
816
(3037692) Legionella sp identified in Specimen by Organism specific culture
16
65
2.47
2.79
1.3
1.5
—
—
—
0
0
(3045788) Cell count panel - Pleural fluid
39
224
1.75
2.78
1.3
1.5
—
—
—
0
0
(3004410) Hemoglobin A1c/Hemoglobin.total in Blood
1507
15768
0.86
2.76
6.8
6.4
mmol/mol
41.2
40.8
0.74
1368
14341
(40768806) Pleura Pathology biopsy report
42
249
1.70
2.69
1.3
1.6
—
—
—
0
0
(3016650) Hepatitis A virus Ab [Presence] in Serum
40
235
1.72
2.65
1.1
1.1
—
—
—
0
0
(3043409) Potassium [Moles/volume] in Arterial blood
87
613
1.44
2.64
10.2
3.9
mmol/l
3.9
3.9
0.24
80
566
(3004716) Salmonella sp identified in Stool by Organism specific culture
94
672
1.42
2.64
1.2
1.3
—
—
—
0
0
(3006184) Hemoglobin [Mass/volume] in Capillary blood
66
440
1.52
2.64
2.8
2.2
g/l
119.7
127.8
1.74
50
327
(3036603) Volume of Urine
23
113
2.05
2.61
1.3
1.5
ml
1918.6
1736.4
—
5
28
(36304997) Mycobacterium tuberculosis stimulated gamma interferon release by CD4+ and CD8+ T-cells [Units/volume] in Blood
70
475
1.49
2.58
1.6
1.6
iu/ml
0.6
12.9
0.55
16
106
(3044936) Clostridioides difficile toxin A+B [Presence] in Stool by Immunoassay
12
44
2.74
2.54
1.2
1.2
—
—
—
0
0
(3013727) Leukocytes other/100 leukocytes in Blood
15
62
2.43
2.54
1.7
4.8
%
54.9
52.8
0.16
15
57
(3041096) Erythrocytes [Presence] in Urine by Automated
501
4416
1.17
2.53
5.1
3.7
—
—
—
0
0
(43055361) Metamyelocytes/Leukocytes [Pure number fraction] in Blood by Manual count
21
101
2.09
2.53
2.8
3.8
—
—
—
0
0
(3002109) Cholesterol in LDL/Cholesterol in HDL [Mass Ratio] in Serum or Plasma
60
887
0.67
2.50
1.5
1.8
—
—
—
0
0
(3010421) pH of Blood
79
554
1.44
2.48
5.2
4.4
ph
7.4
7.4
0.12
65
459
(40758895) Direct antiglobulin test.complement C3d specific reagent [Presence] on Red Blood Cells
23
116
1.99
2.45
1.9
1.3
—
—
—
0
0
(40758897) Direct antiglobulin test.IgG specific reagent [Presence] on Red Blood Cells
23
116
1.99
2.45
1.9
1.3
—
—
—
0
0
(3035637) Corticotropin [Mass/volume] in Plasma
33
188
1.77
2.45
1.2
1.6
—
—
—
0
0
(40768795) Lymph node Pathology biopsy report
30
166
1.82
2.45
1.1
1.2
—
—
—
0
0
(3013527) Hepatitis B virus core IgM Ab [Presence] in Serum
39
234
1.68
2.42
1.1
1.2
—
—
—
0
0
(3040853) Adenovirus DNA [Identifier] in Specimen by NAA with probe detection
66
449
1.48
2.42
1.7
1.6
—
—
—
0
0
(3013784) Calcium.ionized [Moles/volume] in Serum or Plasma by Ion-selective membrane electrode (ISE)
10
34
2.95
2.41
1.0
1.6
—
—
—
0
0
(3044491) Cholesterol non HDL [Mass/volume] in Serum or Plasma
35
578
0.60
2.40
1.3
1.5
—
—
—
0
0
(3042194) Human metapneumovirus RNA [Presence] in Specimen by NAA with probe detection
68
467
1.47
2.39
1.7
1.6
—
—
—
0
0
(3049717) Cytology report of Urine Cyto stain
114
859
1.35
2.36
3.1
2.7
—
—
—
0
0
(3032035) Polymorphonuclear cells/100 leukocytes in Blood
53
346
1.54
2.36
3.2
3.4
%
57.1
59.2
0.49
53
346
(3049539) Genetic diseases [Identifier] in Blood or Tissue by FISH Nominal
23
118
1.96
2.35
1.4
1.2
—
—
—
0
0
(3003327) Ova and parasites identified in Stool by Light microscopy
64
436
1.48
2.34
1.9
1.6
—
—
—
0
0
(3011412) CD3 cells [#/volume] in Blood
26
140
1.87
2.32
1.6
1.9
e9/l
1.0
1.0
0.05
15
78
(3018921) Toxoplasma gondii IgA Ab [Units/volume] in Serum
9
28
3.22
2.30
1.0
1.1
—
—
—
0
0
(3011648) Oxygen content in Venous blood
27
148
1.83
2.28
2.4
1.7
%
10.1
10.8
0.39
27
148
(3001467) Alkaline phosphatase.bone [Enzymatic activity/volume] in Serum or Plasma
32
185
1.74
2.28
1.2
1.2
u/l
86.5
52.4
0.49
20
128
(42870298) TPMT gene c.238G>C+460G>A+719A>G [Identifier] in Blood or Tissue by Molecular genetics method Narrative
7
18
3.90
2.25
1.0
1.0
—
—
—
0
0
(3015816) F5 gene p.Arg506Gln [Presence] in Blood or Tissue by Molecular genetics method
33
194
1.71
2.23
1.2
1.1
—
—
—
0
0
(3048816) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Blood
197
1609
1.25
2.23
4.6
3.8
mmol/l
1.2
1.2
0.19
182
1388
(3027545) Mycoplasma pneumoniae Ab [Presence] in Serum by Immunoassay
17
338
0.50
2.22
1.2
1.3
—
—
—
0
0
(3017446) Testosterone [Moles/volume] in Serum or Plasma
88
1187
0.73
2.22
2.2
2.2
nmol/l
10.7
12.5
1.20
82
1022
(40761511) CBC panel - Blood by Automated count
1772
17163
1.17
2.21
32.2
16.0
—
—
—
0
0
(40769539) Bacteria identified based on 16S rRNA gene [Identifier] in Specimen by Sequencing
59
402
1.48
2.18
1.7
1.6
—
—
—
0
0
(3012202) Varicella zoster virus DNA [Presence] in Specimen by NAA with probe detection
16
74
2.17
2.14
1.0
1.2
—
—
—
0
0
(3007778) Kappa light chains/Lambda light chains [Mass Ratio] in Serum
92
682
1.36
2.14
2.5
3.3
ratio
1.4
1.7
—
9
48
(44790047)
35
212
1.66
2.13
1.4
1.5
—
—
—
0
0
(44806118)
35
212
1.66
2.13
1.4
1.5
—
—
—
0
0
(44790048)
35
212
1.66
2.13
1.4
1.5
—
—
—
0
0
(44790049)
35
212
1.66
2.13
1.4
1.5
—
—
—
0
0
(3005532) Lymphocytes/100 leukocytes in Pleural fluid
19
95
2.01
2.10
1.3
1.4
%
64.8
64.2
0.02
13
75
(3024932) HLA-DR beta [Type]
10
37
2.71
2.10
1.0
1.1
—
—
—
0
0
(3047826) Mullerian inhibiting substance [Mass/volume] in Serum or Plasma
11
43
2.57
2.09
3.5
1.2
ug/l
15.2
2.3
—
6
32
(3005013) Prostate Specific Ag Free [Mass/volume] in Serum or Plasma
342
3918
0.85
2.07
2.9
3.2
ug/l
0.8
0.8
0.53
232
2734
(3012501) Base excess in Blood by calculation
66
466
1.43
2.05
5.7
4.7
mmol/l
2.9
2.6
0.32
50
326
(3021614) Rheumatoid factor [Units/volume] in Serum or Plasma
217
2585
0.82
2.03
1.2
1.2
iu/ml
58.2
36.7
0.48
67
823
(3034860) Kappa light chains.free [Mass/volume] in Serum
94
706
1.35
2.03
2.4
3.3
mg/l
123.0
59.3
0.50
82
578
(3027529) Toxoplasma gondii IgM Ab [Units/volume] in Serum
23
125
1.85
2.02
1.3
1.2
—
—
—
0
0
(3001964) Herpes simplex virus Ag [Presence] in Specimen
12
50
2.41
2.02
1.3
1.4
—
—
—
0
0
(3037522) Nuclear Ab [Titer] in Serum
237
1996
1.21
2.02
1.3
1.3
titre
504.9
554.3
0.17
53
447
(3047169) Lambda light chains.free [Mass/volume] in Serum or Plasma
94
707
1.34
2.01
2.4
3.3
mg/l
40.7
80.3
1.20
82
581
(3000012) Reticulocyte production index
19
97
1.97
2.00
1.5
1.7
—
—
—
0
0
(3043747) Beta 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
822
1.32
1.99
3.0
2.5
g/l
3.8
3.8
0.15
77
595
(3020565) Legionella pneumophila DNA [Presence] in Specimen by NAA with probe detection
39
248
1.58
1.98
1.4
1.5
—
—
—
0
0
(3023465) Gamma globulin [Mass/volume] in Serum or Plasma by Electrophoresis
102
779
1.32
1.98
3.0
2.5
g/l
10.4
10.4
0.01
91
661
(3043723) Beta 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
823
1.32
1.97
3.0
2.5
—
—
—
0
0
(3005229) Alpha 2 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
107
824
1.31
1.96
3.0
2.5
g/l
7.5
7.5
0.15
80
618
(1616796) Gas panel - Central venous blood
64
454
1.42
1.95
4.9
3.8
—
—
—
0
0
(3009804) Carcinoembryonic Ag [Mass/volume] in Pleural fluid
14
64
2.20
1.94
1.1
1.2
ug/l
533.0
492.5
—
9
33
(3024471) HLA-A [Type]
10
39
2.57
1.92
1.0
1.0
—
—
—
0
0
(3051611) Lipemic interference index of Serum or Plasma
34
211
1.62
1.92
7.2
3.5
—
—
—
0
0
(40765161) Human bocavirus DNA [Presence] in Specimen by NAA with probe detection
50
341
1.48
1.88
1.8
1.6
—
—
—
0
0
(3010521) Mycoplasma pneumoniae IgM Ab [Presence] in Serum by Immunoassay
19
343
0.55
1.87
1.1
1.1
—
—
—
0
0
(3018251) Fasting glucose [Moles/volume] in Serum or Plasma
1587
16402
0.88
1.87
5.0
5.0
mmol/l
6.2
6.1
2.37
1418
14634
(3014959) Toxoplasma gondii IgG Ab [Units/volume] in Serum
23
129
1.79
1.85
2.5
2.4
—
—
—
0
0
(36660697) Celiac disease serology panel - Serum
142
1144
1.26
1.85
1.2
1.2
—
—
—
0
0
(3026493) Urate [Moles/volume] in Serum or Plasma
531
4810
1.14
1.82
3.3
2.9
umol/l
4625.8
6855.0
0.52
466
4079
(3009041) Cardiolipin IgG Ab [Units/volume] in Serum by Immunoassay
32
199
1.62
1.80
1.3
1.2
u/ml
3.9
6.1
0.55
19
88
(40763086) Leukocyte esterase [Presence] in Urine by Automated test strip
702
6474
1.12
1.79
5.2
4.3
—
—
—
0
0
(4268621)
24
138
1.75
1.79
2.2
2.3
—
—
—
0
0
(40760888) Immunoglobulin light chains.free panel - Serum
71
523
1.37
1.77
2.1
3.5
—
—
—
0
0
(3025023) Rhinovirus RNA [Presence] in Specimen by NAA with probe detection
30
185
1.63
1.75
1.5
1.6
—
—
—
0
0
(3004490) Bicarbonate [Moles/volume] standard in Capillary blood
100
777
1.30
1.75
5.3
4.0
mmol/l
24.5
24.9
0.59
92
707
(3002385) Erythrocyte distribution width [Ratio]
1400
13432
1.12
1.73
43.7
20.4
%
14.7
13.9
46.07
1382
13095
(1001833) Epstein Barr virus DNA [Units/volume] (viral load) in Blood by NAA with probe detection
7
24
2.92
1.72
1.1
2.5
—
—
—
0
0
(4306422)
31
194
1.61
1.72
1.2
1.2
—
—
—
0
0
(40757349) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Blood
11
48
2.30
1.70
1.0
1.9
—
—
—
0
0
(40761539) Cells [Type] in Urine sediment by Light microscopy
11
48
2.30
1.70
1.0
1.2
—
—
—
0
0
(3043109) Cytology report of Tissue fine needle aspirate Cyto stain
62
450
1.39
1.70
1.2
1.2
—
—
—
0
0
(40768800) Prostate Pathology biopsy report
27
431
0.62
1.69
1.1
1.2
—
—
—
0
0
(40762485) Glomerular basement membrane Ab [Units/volume] in Serum by Immunoassay
26
156
1.67
1.69
1.0
1.1
u/ml
—
—
—
0
0
(3000504) BK virus DNA [Units/volume] (viral load) in Serum or Plasma by NAA with probe detection
6
19
3.16
1.66
4.5
4.8
—
—
—
0
0
(3000108) Respiratory syncytial virus B RNA [Presence] in Specimen by NAA with probe detection
15
76
1.98
1.64
2.0
1.7
—
—
—
0
0
(3005156) Respiratory syncytial virus A RNA [Presence] in Specimen by NAA with probe detection
15
76
1.98
1.64
2.0
1.7
—
—
—
0
0
(3011363) Streptococcus pneumoniae Ag [Presence] in Urine
22
127
1.74
1.64
1.2
1.2
—
—
—
0
0
(3016881) Enterovirus RNA [Presence] in Specimen by NAA with probe detection
31
197
1.58
1.63
1.5
1.6
—
—
—
0
0
(3002482) Mycoplasma pneumoniae DNA [Presence] in Specimen by NAA with probe detection
46
319
1.45
1.62
1.5
1.5
—
—
—
0
0
(3018387) Mycoplasma pneumoniae IgG Ab [Units/volume] in Serum
9
188
0.48
1.61
1.0
1.1
—
14.1
—
0
8
(40767503) Oxygen content in Capillary blood by calculation
60
438
1.38
1.60
3.0
2.5
%
14.9
15.9
0.99
34
219
(3044355) Beta 2 glycoprotein 1 IgG Ab [Units/volume] in Serum or Plasma by Immunoassay
32
206
1.56
1.59
1.3
1.2
u/ml
8.6
4.6
0.43
16
62
(21493195) Respiratory pathogens DNA and RNA tested for in Respiratory system specimen by NAA with probe detection
15
77
1.95
1.59
2.0
1.7
—
—
—
0
0
(3035880) pH of Pleural fluid
23
136
1.70
1.59
1.3
1.3
—
—
—
0
0
(3011397) Hemoglobin [Presence] in Urine by Test strip
455
4116
1.13
1.59
3.9
3.9
—
—
—
0
0
(3042602) Urea [Moles/volume] in Serum or Plasma --post dialysis
6
20
3.01
1.58
8.0
10.6
mmol/l
5.7
5.7
—
6
20
(3014038) Collagen crosslinked N-telopeptide [Moles/volume] in Urine
6
20
3.01
1.58
1.3
1.4
—
—
—
0
0
(3009445) Proteinase 3 Ab [Units/volume] in Serum
95
745
1.29
1.57
1.7
1.4
u/ml
3.6
11.5
—
5
17
(3045683) HLA typing for celiac disease panel - Blood or Tissue
12
57
2.11
1.55
1.0
1.0
—
—
—
0
0
(43054914) Glucose tolerance 2 hours panel - Serum or Plasma
129
1571
0.81
1.55
1.6
1.6
—
—
—
0
0
(3008898) HLA-B27 [Presence]
25
396
0.63
1.54
1.1
1.1
—
—
—
0
0
(3042111) Morphology [Interpretation] in Bone marrow Narrative
51
366
1.40
1.52
1.7
1.5
—
—
—
0
0
(723474) SARS-CoV-2 (COVID-19) IgG Ab [Presence] in Serum or Plasma by Immunoassay
7
27
2.60
1.51
1.0
1.1
—
—
—
0
0
(3004383) Neutrophil cytoplasmic Ab.classic [Titer] in Serum by Immunofluorescence
48
342
1.41
1.49
1.1
1.2
—
62.2
—
0
9
(3036428) Adenosine deaminase [Enzymatic activity/volume] in Pleural fluid
27
170
1.60
1.49
1.2
1.3
u/l
10.3
12.4
0.48
20
158
(3008295) Osmolality of Serum or Plasma
30
194
1.55
1.48
1.2
1.3
mosm/kgh2o
274.9
277.3
0.27
21
138
(3012477) Bordetella pertussis DNA [Presence] in Specimen by NAA with probe detection
41
284
1.45
1.48
1.5
1.4
—
—
—
0
0
(3021952) Alkaline phosphatase isoenzymes [Enzymatic activity/volume] in Serum or Plasma by Heat stability
44
309
1.43
1.48
1.3
1.2
—
—
—
0
0
(3029338) Protein.monoclonal band 3 [Mass/volume] in Serum or Plasma by Electrophoresis
76
585
1.31
1.46
2.9
2.5
g/l
0.0
0.0
0.49
71
537
(3035320) C reactive protein [Mass/volume] in Body fluid
21
125
1.69
1.43
2.7
2.4
—
—
—
0
0
(3000475) Leukocytes [#/volume] in Synovial fluid
60
448
1.35
1.42
1.6
1.7
e6/l
21357.4
15042.8
0.38
43
326
(3022621) pH of Urine by Test strip
147
1228
1.21
1.42
3.5
3.3
—
—
—
0
0
(3006923) Alanine aminotransferase [Enzymatic activity/volume] in Serum or Plasma
1808
17675
1.13
1.41
20.4
11.0
u/l
25.1
25.3
0.13
1777
16921
(3020073) CD3+CD4+ (T4 helper) cells/CD3+CD8+ (T8 suppressor cells) cells [# Ratio] in Specimen
10
46
2.18
1.40
2.3
1.6
—
—
—
0
0
(3026692) Albumin [Mass/volume] in Peritoneal fluid
11
53
2.08
1.38
1.1
1.4
g/l
17.9
14.9
1.00
11
39
(21494755) Public health laboratory ask at order entry panel
62
811
0.76
1.37
1.2
1.4
—
—
—
0
0
(3040363) Hepatitis A virus IgG Ab [Presence] in Serum by Immunoassay
22
135
1.64
1.36
1.1
1.0
—
—
—
0
0
(3002523) Influenza virus A Ag [Presence] in Specimen
8
161
0.50
1.36
1.4
1.1
—
—
—
0
0
(46235128) Lupus anticoagulant aPTT and dRVVT screening panel W Reflex
14
75
1.87
1.34
1.1
1.1
—
—
—
0
0
(1002224) Polysomnography panel
34
488
0.69
1.34
1.1
1.1
—
—
—
0
0
(3010156) C reactive protein [Mass/volume] in Serum or Plasma by High sensitivity method
30
440
0.68
1.32
2.0
1.7
mg/l
6.5
4.4
0.50
23
339
(3020013) Alkaline phosphatase.intestinal [Enzymatic activity/volume] in Serum or Plasma
19
113
1.69
1.31
1.5
1.6
u/l
1.1
7.0
—
8
57
(3006695) Toxoplasma gondii DNA [Presence] in Specimen by NAA with probe detection
6
24
2.50
1.30
2.0
1.9
—
—
—
0
0
(3035544) Cardiolipin IgG Ab [Units/volume] in Serum or Plasma
8
34
2.36
1.29
1.1
1.1
—
—
—
0
0
(21492711) Cytomegalovirus IgG Ab avidity [Presence] in Serum or Plasma by Immunoassay
16
91
1.76
1.29
1.1
1.2
—
—
—
0
0
(3008486) Thyroxine (T4) free [Moles/volume] in Serum or Plasma
1209
12567
0.92
1.28
4.0
3.9
pmol/l
14.9
15.0
0.86
1094
11190
(3045783) Sodium and Potassium panel [Moles/volume] - Serum or Plasma
207
2370
0.86
1.28
10.1
8.1
—
—
—
0
0
(3027456) Digoxin [Moles/volume] in Serum or Plasma
67
518
1.30
1.28
3.0
3.2
nmol/l
0.9
0.8
0.34
51
402
(3017895) Helicobacter pylori Ab [Units/volume] in Serum
69
536
1.30
1.27
1.6
1.6
—
—
—
0
0
(21494814) CD8 cells/100 lymphocytes in Specimen
11
55
2.01
1.27
1.9
1.6
—
—
—
0
0
(3039602) Calcium.ionized [Moles/volume] adjusted to pH 7.4 in Capillary blood
8
35
2.29
1.27
1.9
1.9
mmol/l
1.2
1.2
—
8
35
(3001893) Eosinophils/100 leukocytes in Pleural fluid
14
77
1.82
1.25
1.4
1.5
%
2.6
2.7
—
9
66
(3003740) Influenza virus B Ag [Presence] in Specimen
8
160
0.50
1.24
1.4
1.1
—
—
—
0
0
(3022575) Varicella zoster virus IgG Ab [Units/volume] in Serum
9
45
2.00
1.23
1.0
1.1
miu/ml
2494.6
1668.0
—
9
45
(42868691) Thyroxine (T4) free [Moles/volume] in Serum or Plasma by Dialysis
10
49
2.05
1.22
1.9
1.6
pmol/l
16.1
14.2
—
10
37
(3003191) Choriogonadotropin (pregnancy test) [Presence] in Serum or Plasma
16
93
1.73
1.21
1.3
1.4
—
—
—
0
0
(3003338) MCHC [Mass/volume]
1386
13409
1.09
1.21
46.3
22.1
g/l
328.7
331.5
20.41
1374
13265
(3027135) IgG subclass 1 [Mass/volume] in Serum
21
132
1.60
1.20
1.2
1.3
g/l
7.7
7.3
0.18
16
92
(36032419) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Immunoassay
29
418
0.69
1.19
1.8
1.6
—
—
—
0
0
(1002183) Plasma cells monotypic population [Identifier] in Bone marrow by Flow cytometry (FC)
6
26
2.31
1.18
1.0
1.2
—
—
—
0
0
(3036035) von Willebrand factor (vWf) Ag actual/normal in Platelet poor plasma by Immunoassay
8
38
2.11
1.18
2.5
2.9
%
222.6
188.1
—
8
32
(3035797) Protein.monoclonal band 2 [Mass/volume] in Serum or Plasma by Electrophoresis
77
615
1.26
1.17
2.9
2.4
g/l
0.0
0.0
0.07
72
565
(3030905) Polymorphonuclear cells [#/volume] in Blood
45
334
1.35
1.15
3.2
3.1
e9/l
4.8
4.4
0.26
45
334
(3015322) Alpha 1 globulin [Mass/volume] in Serum or Plasma by Electrophoresis
93
763
1.23
1.12
3.2
2.5
g/l
3.2
3.2
0.10
77
607
(3028433) Virus identified in Specimen by Culture
11
58
1.90
1.12
1.2
1.3
—
—
—
0
0
(3012220) Varicella zoster virus IgM Ab [Presence] in Serum by Immunoassay
21
135
1.56
1.11
1.1
1.1
—
—
—
0
0
(3003265) Liver kidney microsomal Ab [Titer] in Serum by Immunofluorescence
19
120
1.59
1.08
1.3
1.1
—
—
—
0
0
(3045142) Bone marrow Pathology biopsy report
32
227
1.42
1.08
1.4
1.3
—
—
—
0
0
(3050380) Cytology report of Cervical or vaginal smear or scraping Cyto stain
18
279
0.64
1.07
1.4
1.4
—
—
—
0
0
(37020937) Giardia lamblia DNA [Presence] in Stool by NAA with probe detection
16
97
1.65
1.06
1.6
1.2
—
—
—
0
0
(36305771) Cryptosporidium sp DNA [Presence] in Stool by NAA with probe detection
16
97
1.65
1.06
1.6
1.2
—
—
—
0
0
(3020229) Cytomegalovirus DNA [Presence] in Specimen by NAA with probe detection
9
46
1.96
1.03
1.6
1.2
—
—
—
0
0
(4212803)
5
22
2.28
1.03
1.4
1.2
—
—
—
0
0
(3034780) Angiotensin converting enzyme [Enzymatic activity/volume] in Serum or Plasma
84
690
1.23
1.02
1.8
1.8
u/l
37.8
38.4
0.09
73
598
(4094501)
33
449
0.73
1.01
1.2
1.1
—
—
—
0
0
(3000855) Microscopic observation [Identifier] in Vaginal fluid by Gram stain
14
84
1.67
0.97
1.1
1.5
—
—
—
0
0
(3024139) IgG subclass 3 [Mass/volume] in Serum
20
132
1.52
0.97
1.3
1.3
g/l
0.8
0.4
1.26
15
92
(3028192) IgG subclass 2 [Mass/volume] in Serum
20
132
1.52
0.97
1.3
1.3
g/l
3.7
2.8
1.12
15
92
(3012158) Parainfluenza virus 2 RNA [Presence] in Specimen by NAA with probe detection
16
100
1.60
0.96
2.1
1.6
—
—
—
0
0
(3025634) Parainfluenza virus 1 RNA [Presence] in Specimen by NAA with probe detection
16
100
1.60
0.96
2.1
1.6
—
—
—
0
0
(3006262) Parainfluenza virus 3 RNA [Presence] in Specimen by NAA with probe detection
16
100
1.60
0.96
2.1
1.6
—
—
—
0
0
(3038297) Parainfluenza virus 4 RNA [Presence] in Specimen by NAA with probe detection
16
100
1.60
0.96
2.1
1.6
—
—
—
0
0
(3028286) Albumin [Mass/volume] in Serum or Plasma by Electrophoresis
79
651
1.22
0.95
3.1
2.3
g/l
35.5
37.3
1.71
71
562
(3029713) Protein.monoclonal band 1 [Mass/volume] in Serum or Plasma by Electrophoresis
85
706
1.21
0.95
3.2
2.6
g/l
1.2
1.3
0.09
76
608
(3044927) Protein electrophoresis panel - Urine
33
242
1.37
0.94
1.2
1.1
—
—
—
0
0
(3025443) Phadiatop IgE Ab [Units/volume] in Serum
9
51
1.77
0.94
1.0
1.0
—
7.8
—
0
5
(3014271) Vancomycin [Susceptibility]
20
133
1.51
0.94
3.4
3.2
—
—
—
0
0
(3027831) CD3-CD16+CD56+ (Natural killer) cells/100 cells in Blood
16
101
1.59
0.93
1.6
1.9
%
15.2
16.2
—
5
40
(3034037) Hematocrit [Volume Fraction] of Mixed venous blood
6
27
2.23
0.93
4.3
9.0
—
—
—
0
0
(40768446) Kidney Pathology biopsy report
9
52
1.73
0.92
1.7
1.6
—
—
—
0
0
(3022907) Direct antiglobulin test.polyspecific reagent [Presence] on Red Blood Cells
10
55
1.82
0.92
1.2
1.2
—
—
—
0
0
(3019497) Choriogonadotropin.beta subunit free [Moles/volume] in Serum or Plasma
6
28
2.15
0.91
2.0
1.9
—
—
—
0
0
(3006571) Polymorphonuclear cells/100 leukocytes in Synovial fluid
30
218
1.38
0.91
1.4
1.6
%
69.4
63.7
0.39
22
135
(3020876) Protein [Mass/time] in 24 hour Urine
23
159
1.45
0.91
1.4
2.0
—
1.1
—
0
5
(3014148) Varicella zoster virus Ab [Titer] in Serum
17
110
1.55
0.90
1.2
1.2
—
—
—
0
0
(3006093) Chlamydia trachomatis DNA [Presence] in Specimen by NAA with probe detection
36
271
1.33
0.89
1.7
1.7
—
—
—
0
0
(3019150) Specific gravity of Urine by Refractometry
408
3793
1.09
0.88
4.6
4.5
kg/l
1.0
1.0
0.19
89
583
(3020191) Ethanol [Moles/volume] in Serum or Plasma
17
111
1.54
0.87
1.8
1.5
promille
1.2
1.1
0.11
12
86
(3012320) Pathologist interpretation of Cerebral spinal fluid tests
6
30
2.00
0.87
1.5
1.2
—
—
—
0
0
(4062490)
20
136
1.47
0.86
1.3
1.3
—
—
—
0
0
(3011371) Neisseria gonorrhoeae DNA [Presence] in Specimen by NAA with probe detection
29
212
1.37
0.86
1.6
1.6
—
—
—
0
0
(3023410) Appearance of Cerebral spinal fluid
22
153
1.44
0.85
1.6
1.3
—
—
—
0
0
(3024980) IgG subclass 4 [Mass/volume] in Serum
30
221
1.36
0.85
1.4
1.6
g/l
0.8
0.9
0.23
24
169
(3020485) Acetaminophen [Moles/volume] in Serum or Plasma
12
72
1.67
0.85
1.9
1.6
umol/l
41.5
95.9
—
6
40
(21493690) Lymphocyte T-cell and B-cell and Natural killer subsets panel - Blood
15
96
1.57
0.84
1.8
2.0
—
—
—
0
0
(3028707) Methadone [Presence] in Urine by Screen method
14
88
1.59
0.84
5.9
2.5
—
—
—
0
0
(3004775) Volume in Urine collected for unspecified duration
22
154
1.43
0.83
3.6
2.2
ml
746.7
623.0
0.55
16
97
(3041642) Human coronavirus 229E RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.9
1.5
—
—
—
0
0
(3038546) Human coronavirus OC43 RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.9
1.5
—
—
—
0
0
(3040359) Human coronavirus NL63 RNA [Presence] in Specimen by NAA with probe detection
24
171
1.41
0.83
1.9
1.5
—
—
—
0
0
(3036048) Francisella tularensis Ab [Titer] in Serum
6
32
1.88
0.81
1.2
1.1
—
—
—
0
0
(1175426) CD3 cells/100 lymphocytes in Blood
16
105
1.53
0.81
1.8
1.9
%
68.4
72.7
0.57
16
95
(3027923) C peptide [Moles/volume] in Serum or Plasma
15
97
1.55
0.81
1.2
1.4
nmol/l
1.3
1.1
0.27
15
74
(3019977) pH of Arterial blood
17
114
1.50
0.79
2.2
3.1
ph
7.4
7.4
—
7
39
(3038071) Oxygen [Partial pressure] in Mixed venous blood
6
33
1.82
0.79
4.3
7.9
—
—
—
0
0
(3016436) Lactate dehydrogenase [Enzymatic activity/volume] in Serum or Plasma
13
82
1.59
0.78
1.5
3.5
u/l
190.8
216.8
0.97
13
82
(3038177) Helicobacter pylori Ab [Presence] in Serum
25
182
1.38
0.78
1.2
1.3
—
—
—
0
0
(3037756) Immunofixation for Serum or Plasma
59
484
1.23
0.78
1.6
1.6
—
—
—
0
0
(3015024) Glucose [Moles/volume] in Serum or Plasma --1 hour post dose glucose
0
27
0.00
0.77
0.0
1.3
—
8.0
—
0
15
(3039443) Prostate specific Ag panel - Serum or Plasma
20
280
0.71
0.77
1.7
1.7
—
—
—
0
0
(40768443) Skin Pathology biopsy report
92
789
1.17
0.76
1.2
1.2
—
—
—
0
0
(40764999) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (CKD-EPI)
1602
15714
1.07
0.76
32.6
15.9
ml/min/173m2
75.2
74.3
0.85
1427
13045
(3012447) Hantavirus puumala IgG Ab [Titer] in Serum
24
175
1.38
0.74
1.2
1.1
—
—
—
0
0
(3021513) Carbon dioxide [Partial pressure] in Mixed venous blood
7
38
1.84
0.73
5.3
7.6
—
—
—
0
0
(3004451) EKG impression Narrative
15
100
1.50
0.72
1.1
1.2
—
—
—
0
0
(3014300) Beta 2 glycoprotein 1 IgM Ab [Units/volume] in Serum
5
25
2.00
0.72
1.0
1.2
—
—
—
0
0
(3018851) Theophylline [Moles/volume] in Serum or Plasma
5
25
2.00
0.72
1.8
1.6
umol/l
39.8
42.9
—
5
25
(3023420) DNA double strand Ab [Units/volume] in Serum
20
142
1.41
0.72
1.2
1.3
—
30.8
—
0
8
(3007461) Platelets [#/volume] in Blood
1849
18247
1.09
0.71
50.3
24.5
e9/l
254.0
242.9
7.71
1822
17693
(3000081) cloZAPine [Moles/volume] in Serum or Plasma
9
57
1.58
0.71
6.8
17.9
nmol/l
1636.7
1537.7
—
9
57
(3024731) MCV [Entitic volume]
1849
18249
1.08
0.71
50.1
24.4
fl
91.2
91.6
2.79
1831
17893
(3039355) Methicillin resistant Staphylococcus aureus [Presence] in Nose by Organism specific culture
5
26
1.93
0.70
1.8
2.3
—
—
—
0
0
(3035941) MCH [Entitic mass]
1849
18250
1.08
0.70
50.1
24.4
pg
30.0
30.4
13.62
1830
17890
(3026361) Erythrocytes [#/volume] in Blood
1849
18251
1.08
0.70
50.3
24.5
e12/l
4.2
4.4
53.92
1815
17623
(42868544) Hantavirus puumala IgM Ab [Presence] in Serum or Plasma by Immunofluorescence
35
274
1.28
0.70
1.2
1.1
—
—
—
0
0
(3000963) Hemoglobin [Mass/volume] in Blood
1849
18254
1.08
0.69
50.7
24.7
g/l
123.9
133.2
101.89
1829
17911
(3020682) Albumin/Creatinine [Ratio] in Urine
628
5998
1.07
0.68
4.1
3.9
mg/mmol
12.1
9.4
0.59
443
3791
(3031478) Chlamydophila pneumoniae DNA [Presence] in Specimen by NAA with probe detection
33
257
1.29
0.68
1.5
1.5
—
—
—
0
0
(44816752) ERBB2 gene copy number/nucleus in Tissue by FISH
12
77
1.56
0.68
1.1
1.1
—
—
—
0
0
(46235760) Methicillin resistant Staphylococcus aureus [Presence] in Pharynx by Organism specific culture
5
27
1.85
0.68
1.8
2.3
—
—
—
0
0
(3028371) Actinomyces sp identified in Specimen by Organism specific culture
5
27
1.85
0.68
1.4
1.2
—
—
—
0
0
(3051387) C reactive protein [Mass/volume] in Capillary blood
50
410
1.22
0.68
4.6
3.6
mg/l
35.3
29.3
0.40
33
265
(3023659) Complement C1 esterase inhibitor.functional/Complement C1 esterase inhibitor.total in Serum or Plasma
7
42
1.67
0.68
1.4
1.3
%
128.7
109.8
—
7
34
(3010813) Leukocytes [#/volume] in Blood
1849
18257
1.08
0.67
50.3
24.5
e9/l
7.2
6.9
5.07
1816
17633
(1001509) Gas and Carbon monoxide and Electrolytes panel - Arterial blood
15
102
1.47
0.67
1.6
2.0
—
—
—
0
0
(3014326) Insulin-like growth factor-I [Moles/volume] in Serum or Plasma
5
91
0.55
0.67
1.0
1.6
nmol/l
15.3
16.5
—
5
81
(21494890) Protein electrophoresis panel - 24 hour Urine
28
214
1.31
0.66
1.8
2.1
—
—
—
0
0
(4034850)
47
570
0.82
0.65
12.6
11.9
—
—
—
0
0
(3023150) Myeloperoxidase Ab [Units/volume] in Serum
37
295
1.26
0.65
1.4
1.4
—
—
—
0
0
(3034426) Prothrombin time (PT)
7
44
1.59
0.65
1.1
1.4
—
—
—
0
0
(3014037) CD3+CD4+ (T4 helper) cells/100 cells in Blood
15
103
1.46
0.65
1.9
2.8
%
41.0
38.3
—
6
39
(1617658) Protocol used for examination of sentinel lymph nodes
8
128
0.62
0.64
1.0
1.0
—
—
—
0
0
(3045716) Anion gap in Serum or Plasma
13
87
1.50
0.63
2.3
2.6
mmol/l
8.4
9.6
—
8
68
(3019902) Methicillin resistant Staphylococcus aureus [Presence] in Specimen by Organism specific culture
223
2054
1.10
0.63
5.2
3.7
—
—
—
0
0
(3026989) Triiodothyronine (T3) Free [Moles/volume] in Serum or Plasma
100
880
1.14
0.62
3.3
3.3
pmol/l
4.2
4.4
0.97
90
754
(3041067) Sjogrens syndrome-A extractable nuclear 52kD Ab [Units/volume] in Serum
19
138
1.38
0.62
1.1
1.1
—
53.4
—
0
16
(3025130) Human papilloma virus identified in Specimen
15
104
1.45
0.62
2.1
1.8
—
—
—
0
0
(3044941) Cell count panel - Synovial fluid
37
297
1.25
0.62
1.6
1.5
—
—
—
0
0
(3032057) Clostridioides difficile [Presence] in Stool
8
49
1.63
0.62
1.8
1.9
—
—
—
0
0
(3004588) Protein electrophoresis panel - Serum or Plasma
163
1482
1.11
0.60
2.6
2.5
—
—
—
0
0
(3021584) Pregnancy associated plasma protein A [Units/volume] in Serum or Plasma
9
139
0.65
0.60
1.6
1.6
—
—
—
0
0
(3050449) Albumin [Mass/time] in Urine collected for unspecified duration
56
472
1.19
0.60
3.3
2.3
ug/min
106.6
97.5
0.07
32
288
(3032836) C peptide [Moles/volume] in Serum or Plasma --fasting
43
353
1.22
0.60
1.5
1.5
nmol/l
0.8
0.8
0.28
37
284
(3042596) Human coronavirus RNA [Presence] in Specimen by NAA with probe detection
28
218
1.29
0.60
2.0
1.6
—
—
—
0
0
(3027035) Albumin [Mass/time] in 24 hour Urine
0
21
0.00
0.60
0.0
1.2
—
819.7
—
0
7
(3011391) Calcitriol [Moles/volume] in Serum or Plasma
18
131
1.38
0.59
1.1
1.2
—
—
—
0
0
(40761536) Microorganisms panel - Urine sediment
162
1475
1.11
0.59
4.9
4.3
—
—
—
0
0
(3046896) Herpes virus 6 DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
8
53
1.51
0.58
1.0
1.1
—
—
—
0
0
(3037826) lamoTRIgine [Moles/volume] in Serum or Plasma
0
23
0.00
0.58
0.0
2.0
—
16.4
—
0
23
(44816893) Food Allergen Mix 50 (Kiwi+Pineapple+Banana+Mango) IgE Ab [Units/volume] in Serum by Multidisk
0
23
0.00
0.58
0.0
1.0
—
—
—
0
0
(3023419) Bacteria identified in Sputum by Culture
34
273
1.25
0.58
2.7
2.5
—
—
—
0
0
(3004905) Lipase [Enzymatic activity/volume] in Serum or Plasma
6
35
1.72
0.57
4.7
2.3
—
38.2
—
0
13
(3016701) Glucose [Moles/volume] in Serum or Plasma --2 hours post dose glucose
12
173
0.69
0.57
1.3
1.2
mmol/l
6.9
7.6
—
7
120
(3006462) Nitrate [Presence] in Urine
12
81
1.48
0.57
4.3
3.9
—
—
—
0
0
(3048879) Bone marrow aspiration report
10
65
1.54
0.55
1.4
1.6
—
—
—
0
0
(3030692) Respiratory virus DNA+RNA [Identifier] in Specimen by NAA with probe detection
34
275
1.24
0.55
1.8
1.6
—
—
—
0
0
(3016894) Varicella zoster virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
13
90
1.45
0.55
1.1
1.2
—
—
—
0
0
(3024135) Streptococcus.beta-hemolytic [Presence] in Throat by Organism specific culture
168
1826
0.91
0.52
1.3
1.3
—
—
—
0
0
(3045156) Carbon dioxide [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
63
1.43
0.52
2.7
2.9
—
—
—
0
0
(3022803) Oxygen [Partial pressure] adjusted to patient's actual temperature in Arterial blood
9
63
1.43
0.52
2.7
2.9
—
—
—
0
0
(3015479) Mycobacterium sp identified in Blood by Organism specific culture
6
40
1.50
0.51
1.2
1.3
—
—
—
0
0
(3007220) Creatine kinase [Enzymatic activity/volume] in Serum or Plasma
601
5785
1.05
0.51
2.4
2.2
u/l
249.5
218.7
0.28
566
5391
(3044242) Glucose [Moles/volume] in Arterial blood
15
109
1.38
0.51
1.5
2.5
—
—
—
0
0
(3042631) Mycobacterium sp identified in Specimen
35
288
1.22
0.50
3.2
2.7
—
—
—
0
0
(46236952) Glomerular filtration rate/1.73 sq M.predicted [Volume Rate/Area] in Serum, Plasma or Blood by Creatinine-based formula (MDRD)
156
1433
1.10
0.50
3.4
2.9
ml/min/173m2
60.9
60.8
0.01
79
616
(3001784) Prostate Specific Ag Free/Prostate specific Ag.total in Serum or Plasma
528
5497
0.95
0.50
4.2
4.6
%
21.9
22.0
0.06
265
2818
(3005570) Glucose [Moles/volume] in Urine
25
198
1.27
0.49
2.1
2.1
—
—
—
0
0
(3026179) Normetanephrine [Moles/volume] in Serum or Plasma
29
235
1.24
0.48
1.3
1.3
nmol/l
0.7
0.7
0.04
29
219
(42869593) Oxyhemoglobin/Hemoglobin.total [Pure mass fraction] in Capillary blood
7
48
1.46
0.46
2.1
3.2
—
—
—
0
0
(3032155) Metanephrine Free [Moles/volume] in Serum or Plasma
27
218
1.24
0.46
1.2
1.2
—
—
—
0
0
(3012516) Albumin [Mass/volume] in Urine
588
5673
1.05
0.46
3.5
3.2
mg/l
268.3
292.4
0.06
441
3620
(3025577) Chromium [Mass/volume] in Blood
8
118
0.68
0.45
1.9
2.1
ug/l
2.5
1.9
—
8
99
(3019145) Choriogonadotropin.beta subunit free [Mass/volume] in Serum or Plasma
5
82
0.61
0.45
1.6
1.5
—
—
—
0
0
(3012565) Volume of 24 hour Urine
5
83
0.60
0.45
2.2
2.7
ml
1894.0
1832.4
—
5
72
(3026470) Cobalt [Mass/volume] in Blood
8
120
0.67
0.45
1.9
2.0
ug/l
3.8
3.0
—
8
105
(3033319) Streptococcus pyogenes Ag [Presence] in Throat
68
769
0.88
0.45
1.1
1.3
—
—
—
0
0
(3050129) First trimester maternal screen panel - Serum or Plasma
5
84
0.59
0.45
2.4
1.4
—
—
—
0
0
(3026389) Candida sp identified in Specimen by Organism specific culture
27
219
1.24
0.45
1.2
1.4
—
—
—
0
0
(3009201) Thyrotropin [Units/volume] in Serum or Plasma
1503
15243
0.96
0.45
4.9
4.8
mu/l
2.0
2.1
0.35
1346
13671
(3017569) Oxygen content in Arterial blood
13
95
1.37
0.43
1.4
2.8
—
—
—
0
0
(3009340) Metanephrine [Moles/volume] in Serum or Plasma
25
202
1.24
0.43
1.2
1.2
nmol/l
—
—
—
0
0
(4133840)
5
32
1.56
0.42
1.2
1.1
—
—
—
0
0
(3021788) Differential panel - Synovial fluid
40
341
1.18
0.42
1.6
1.6
—
—
—
0
0
(3044889) 12 lead EKG panel
1255
12332
1.04
0.42
4.6
4.2
—
—
—
0
0
(3016018) Differential panel - Cerebral spinal fluid
20
158
1.27
0.41
1.4
1.2
—
—
—
0
0
(3010254) Herpes simplex virus identified in Specimen by Organism specific culture
5
33
1.52
0.41
1.0
1.1
—
—
—
0
0
(40766799) MGMT gene methylation score in Tissue by Molecular genetics method
0
15
0.00
0.41
0.0
1.0
—
—
—
0
0
(42869858) Acute and chronic leukemia fusion transcript panel - Blood or Tissue by Molecular genetics method
0
16
0.00
0.41
0.0
1.0
—
—
—
0
0
(3034368) Herpes virus 6 IgM Ab [Presence] in Cerebral spinal fluid
0
16
0.00
0.41
0.0
1.1
—
—
—
0
0
(43534045) MCM6 gene c.-13910C>T and -13915T>G [Identifier] in Blood or Tissue by Molecular genetics method Nominal
74
662
1.12
0.41
1.0
1.0
—
—
—
0
0
(3044009) aPTT.lupus sensitive (LA screen)
0
17
0.00
0.40
0.0
1.2
—
—
—
0
0
(44806071)
0
17
0.00
0.40
0.0
1.1
—
—
—
0
0
(3035929) Mycoplasma pneumoniae Ab [Units/volume] in Cerebral spinal fluid
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(46235168) Fasting glucose [Moles/volume] in Blood
0
18
0.00
0.40
0.0
1.6
—
8.1
—
0
11
(3019174) dRVVT (LA screen)
0
18
0.00
0.40
0.0
1.1
—
—
—
0
0
(706163) SARS-CoV-2 (COVID-19) RNA [Presence] in Respiratory system specimen by NAA with probe detection
875
8545
1.04
0.39
2.6
2.5
—
—
—
0
0
(3022192) Triglyceride [Mass/volume] in Serum or Plasma
8
61
1.31
0.39
2.3
2.6
—
—
—
0
0
(3006441) Cardiolipin IgM Ab [Presence] in Serum by Immunoassay
5
35
1.43
0.39
1.2
1.1
—
—
—
0
0
(3011985) Renin [Units/volume] in Plasma
25
205
1.22
0.39
1.0
1.3
mu/l
52.9
50.2
0.05
20
177
(3019083) Insulin-like growth factor [Moles/volume] in Serum or Plasma
0
19
0.00
0.39
0.0
1.2
—
—
—
0
0
(3005322) IgE [Units/volume] in Serum or Plasma
77
853
0.90
0.38
1.1
1.2
u/ml
122.0
186.8
0.81
71
782
(3025018) Bordetella pertussis Ab [Titer] in Serum
9
66
1.37
0.38
1.1
1.2
—
—
—
0
0
(4211845)
12
89
1.35
0.38
4.3
3.8
—
—
—
0
0
(3036432) Mycobacterium tuberculosis genotype [Identifier] in Isolate
14
107
1.31
0.37
4.3
3.6
—
—
—
0
0
(40765096) Chromosome analysis panel by Banding
9
69
1.31
0.37
1.0
1.1
—
—
—
0
0
(44813793)
12
90
1.34
0.35
1.2
1.0
—
—
—
0
0
(3010566) Parathyrin.intact [Moles/volume] in Serum or Plasma
37
319
1.16
0.35
2.6
2.9
—
—
—
0
0
(1175715) Chlamydophila pneumoniae IgM Ab [Presence] in Serum by Immunoassay
14
179
0.78
0.35
1.0
1.1
—
—
—
0
0
(3051014) Leukocytes [#/area] in Urine sediment by Automated count
21
172
1.22
0.34
1.6
2.0
u/field
2.0
2.1
—
10
58
(3002434) Lupus erythematosus deoxynucleoproteins IgG Ab [Units/volume] in Serum by Immunoassay
43
489
0.88
0.34
1.3
1.7
—
—
—
0
0
(3009508) Creatinine [Moles/volume] in Urine
596
5794
1.04
0.34
3.5
3.1
mmol/l
7.4
7.2
0.53
508
4783
(40768793) Breast Pathology biopsy report
31
361
0.86
0.33
1.3
1.3
—
—
—
0
0
(3032773) Endomysium IgG Ab [Titer] in Serum
14
109
1.29
0.33
1.4
1.1
—
—
—
0
0
(3004616) Nuclear Ab [Presence] in Serum
25
210
1.19
0.32
1.2
1.2
—
—
—
0
0
(44816559) Phosphatidylethanol [Mass/volume] in Blood
21
252
0.83
0.32
1.7
1.3
—
—
—
0
0
(3047189) Immunofixation for 24 hour Urine
7
97
0.72
0.31
1.3
1.6
—
—
—
0
0
(3000492) Spirometry study
135
1437
0.94
0.30
1.6
1.5
—
—
—
0
0
(3018006) Microscopic observation [Identifier] in Cervix by Cyto stain.thin prep
167
1765
0.94
0.30
1.3
1.3
—
—
—
0
0
(3001788) Aldosterone [Moles/volume] in Serum or Plasma
23
194
1.19
0.29
1.0
1.3
pmol/l
203.6
286.2
1.24
18
147
(21494434) Karyotype in Bone marrow
24
204
1.18
0.28
1.0
1.2
—
—
—
0
0
(42529215) Follitropin [Units/volume] in Serum or Plasma by Immunoassay
14
112
1.25
0.28
1.1
1.3
u/l
27.6
30.2
0.14
14
88
(36306090) Helicobacter pylori [Presence] in Tissue by Organism specific culture
11
85
1.30
0.28
1.1
1.1
—
—
—
0
0
(3006653) Thiamine [Moles/volume] in Blood
11
85
1.30
0.28
1.1
1.2
nmol/l
146.8
137.1
0.23
11
85
(3047007) Chlamydophila sp Ab [Presence] in Serum
14
172
0.81
0.27
1.1
1.2
—
—
—
0
0
(4024509)
22
187
1.18
0.26
1.6
1.7
—
—
—
0
0
(42870365) C reactive protein [Mass/volume] in Blood by High sensitivity method
31
272
1.14
0.26
1.8
2.4
mg/l
32.9
24.3
0.34
15
62
(3025245) SCL-70 extractable nuclear Ab [Units/volume] in Serum by Immunoassay
37
329
1.13
0.26
1.1
1.2
u/ml
4.2
5.2
—
5
24
(3050238) Crystals [Presence] in Synovial fluid by Light microscopy
56
511
1.10
0.25
1.4
1.4
—
—
—
0
0
(3029937) Albumin [Presence] in Urine by Test strip
479
4667
1.03
0.25
4.7
4.4
estimate
0.0
0.0
0.88
163
1523
(3029511) Human papilloma virus DNA [Presence] in Specimen by NAA with probe detection
31
351
0.88
0.25
1.2
1.3
—
—
—
0
0
(3027238) Thyroperoxidase Ab [Units/volume] in Serum or Plasma
80
860
0.93
0.25
1.0
1.2
iu/ml
61.3
145.0
3.74
31
318
(3021125) Hepatitis C virus RNA [Presence] in Serum or Plasma by NAA with probe detection
9
76
1.18
0.24
1.2
1.3
—
—
—
0
0
(40760848) Basement membrane zone BP180 Ab [Units/volume] in Serum by Immunoassay
19
161
1.18
0.24
1.4
1.5
u/ml
14.2
20.8
—
5
34
(3013180) HIV 1 RNA [Units/volume] (viral load) in Serum or Plasma by Probe with amplification
6
83
0.72
0.24
1.5
5.4
—
63.0
—
0
20
(3008536) Aspergillus sp Ab [Presence] in Serum
5
39
1.28
0.23
1.6
1.3
—
—
—
0
0
(3011288) Drugs identified in Urine by Screen method
16
134
1.20
0.23
1.4
2.9
—
—
—
0
0
(36033641) SARS-CoV-2 (COVID-19) Ag [Presence] in Upper respiratory specimen by Rapid immunoassay
26
228
1.14
0.22
1.3
1.5
—
—
—
0
0
(3010838) Calcium [Moles/time] in 24 hour Urine
7
91
0.77
0.22
1.0
1.5
—
11.7
—
0
5
(3003329) Lymphocytes/100 leukocytes in Synovial fluid
19
163
1.17
0.21
1.2
1.4
%
26.9
28.7
0.08
14
99
(40760435) Tropomyosin IgE Ab [Units/volume] in Serum
0
11
0.00
0.21
0.0
1.0
—
—
—
0
0
(3028334) Neisseria gonorrhoeae [Presence] in Specimen by Organism specific culture
0
11
0.00
0.21
0.0
1.5
—
—
—
0
0
(21493619) Chromosome 12 trisomy and chromosome region 11q22.3 and 13q14 and 17p13.1 deletion in Blood or Tissue by FISH
0
10
0.00
0.21
0.0
1.1
—
—
—
0
0
(3018559) Microscopic observation [Identifier] in Buccal smear by Cyto stain
23
262
0.88
0.21
1.1
1.1
—
—
—
0
0
(3024316) Viscosity of Plasma
0
12
0.00
0.21
0.0
1.6
—
1.5
—
0
6
(43055514) Macroprolactin [Presence] in Serum or Plasma
0
12
0.00
0.21
0.0
1.2
—
—
—
0
0
(1175310) Leucine-rich glioma-inactivated protein 1 Ab [Presence] in Cerebral spinal fluid by Cell binding immunofluorescent assay
0
12
0.00
0.21
0.0
1.0
—
—
—
0
0
(42868766) Dientamoeba fragilis DNA [Presence] in Stool by NAA with probe detection
5
43
1.16
0.21
2.2
1.1
—
—
—
0
0
(3043257) Herpes virus 6 IgG Ab [Presence] in Cerebral spinal fluid
0
13
0.00
0.21
0.0
1.1
—
—
—
0
0
(3032868) Hemoglobin electrophoresis panel in Blood
0
13
0.00
0.21
0.0
1.2
—
—
—
0
0
(3033386) Bacteria [Presence] in Cerebral spinal fluid by Light microscopy
10
80
1.25
0.20
1.0
1.4
—
—
—
0
0
(3027231) Wheat IgE Ab [Units/volume] in Serum
0
14
0.00
0.20
0.0
1.0
—
—
—
0
0
(3006804) Neuronal Ab [Presence] in Cerebral spinal fluid
0
14
0.00
0.20
0.0
1.1
—
—
—
0
0
(3013139) Helicobacter pylori Ag [Presence] in Stool
111
1055
1.05
0.19
1.2
1.3
—
—
—
0
0
(37020300) Entamoeba histolytica DNA [Presence] in Stool by NAA with probe detection
6
51
1.18
0.19
2.0
1.1
—
—
—
0
0
(3024950) Chlamydia trachomatis DNA [Presence] in Urine by NAA with probe detection
65
692
0.94
0.17
1.7
1.7
—
—
—
0
0
(3011166) Borrelia burgdorferi Ab [Presence] in Cerebral spinal fluid
12
142
0.84
0.17
1.1
1.1
—
—
—
0
0
(3012413) Glucose [Moles/volume] in Serum or Plasma --2 hours post meal
13
110
1.18
0.17
1.2
1.2
mmol/l
10.0
11.3
—
6
38
(3024172) Erythropoietin (EPO) [Units/volume] in Serum or Plasma
38
349
1.09
0.17
1.1
1.2
u/l
33.5
46.9
0.60
31
303
(3053028) Streptococcus sp identified in Specimen by Organism specific culture
5
69
0.72
0.17
1.0
1.2
—
—
—
0
0
(3006999) Ribonucleoprotein extractable nuclear Ab [Units/volume] in Serum
44
408
1.08
0.16
1.2
1.2
u/ml
20.0
6.0
0.34
12
67
(4146454)
19
214
0.89
0.15
2.4
2.6
—
—
—
0
0
(3007847) Interleukin 2 Receptor Soluble [Units/volume] in Serum or Plasma
6
76
0.79
0.15
2.0
2.2
u/ml
967.3
1465.9
—
6
76
(3017704) Immunofixation for Urine
15
130
1.15
0.15
1.3
1.7
—
—
—
0
0
(46235831) Pregnancy associated plasma protein A [Multiple of the median] adjusted in Serum or Plasma
6
79
0.76
0.15
1.5
1.4
—
—
—
0
0
(3008714) Choriogonadotropin [Multiple of the median] adjusted in Serum or Plasma
6
79
0.76
0.15
1.5
1.4
—
—
—
0
0
(40763531) Fetal Nuchal fold [Multiple of the median] Thickness adjusted for maternal weight
6
79
0.76
0.15
1.7
1.4
—
—
—
0
0
(3049207) Fetal Trisomy 21 risk [Likelihood] Based on maternal age
6
79
0.76
0.15
1.5
1.4
—
—
—
0
0
(3014051) Protein [Presence] in Urine by Test strip
47
439
1.07
0.15
1.8
2.2
—
—
—
0
0
(3014791) Apolipoprotein B [Mass/volume] in Serum or Plasma
11
93
1.18
0.14
1.2
1.5
g/l
0.9
1.0
0.10
11
93
(44816844) Macroprolactin [Units/volume] in Serum or Plasma
7
90
0.78
0.14
1.1
1.5
—
—
—
0
0
(3016921) Smith extractable nuclear Ab [Units/volume] in Serum
43
402
1.07
0.13
1.2
1.2
u/ml
6.5
3.8
—
8
41
(40759883) Oligoclonal Bands IgG [Presence] in Cerebral spinal fluid by Isoelectric focusing
8
96
0.83
0.13
1.0
1.0
—
—
—
0
0
(3044290) Cell count panel - Cerebral spinal fluid
29
313
0.93
0.12
1.4
1.3
—
—
—
0
0
(3001019) Free T4 and TSH panel - Serum or Plasma
42
446
0.94
0.12
1.4
1.7
—
—
—
0
0
(40764126) Parainfluenza virus RNA [Presence] in Specimen by NAA with probe detection
18
162
1.11
0.11
2.0
1.5
—
—
—
0
0
(3027450) Sjogrens syndrome-B extractable nuclear Ab [Units/volume] in Serum
45
425
1.06
0.11
1.2
1.2
u/ml
10.7
33.4
—
5
21
(3042585) Pyridoxine [Moles/volume] in Serum or Plasma
5
44
1.14
0.10
1.0
1.2
nmol/l
99.0
128.5
—
5
33
(3011547) Coagulation factor VII activity actual/normal in Platelet poor plasma by Coagulation assay
5
45
1.11
0.09
1.2
1.2
%
87.6
99.6
—
5
40
(3016914) Bacteria identified in Cerebral spinal fluid by Culture
18
164
1.10
0.09
1.1
1.3
—
—
—
0
0
(3020491) Glucose [Moles/volume] in Blood
15
135
1.11
0.09
1.9
2.3
mmol/l
8.3
7.1
—
10
84
(3007449) CD3+CD8+ (T8 suppressor) cells/100 cells in Blood
5
46
1.09
0.09
1.0
2.3
%
31.0
28.9
—
5
40
(3006245) CD3-CD19+ cells/100 cells in Blood
5
47
1.06
0.09
1.0
2.3
%
13.2
8.0
—
5
39
(3036535) Thyroglobulin [Mass/volume] in Serum or Plasma
10
87
1.15
0.09
5.9
6.6
—
—
—
0
0
(40766183) Gliadin peptide IgA Ab [Units/volume] in Serum by Immunoassay
19
174
1.09
0.09
1.2
1.1
u/ml
25.1
2.1
—
6
57
(3045424) Erythrocytes [Presence] in Urine
30
282
1.06
0.09
1.9
1.4
—
—
—
0
0
(40757373) Influenza virus identified in Isolate
6
57
1.05
0.08
1.7
1.6
—
—
—
0
0
(3050898) Methicillin resistant Staphylococcus aureus [Presence] in Genital specimen by Organism specific culture
13
117
1.11
0.08
2.5
2.4
—
—
—
0
0
(3045414) Leukocytes [Presence] in Urine
82
796
1.03
0.08
1.9
2.0
—
—
—
0
0
(42868674) Cholesterol in HDL/Cholesterol.total [Molar ratio] in Serum or Plasma
232
2286
1.02
0.07
4.4
4.7
%
32.8
33.2
0.21
166
1470
(4027681)
8
77
1.04
0.07
1.0
1.2
—
—
—
0
0
(40761535) Cells panel - Urine sediment
159
1619
0.98
0.07
4.0
3.6
—
—
—
0
0
(3008733) Herpes simplex virus DNA [Presence] in Cerebral spinal fluid by NAA with probe detection
9
87
1.03
0.07
1.1
1.1
—
—
—
0
0
(3025547) Thyroglobulin Ab [Units/volume] in Serum or Plasma
14
128
1.09
0.06
4.6
5.0
u/ml
62.6
38.4
—
6
37
(3017044) Thyrotropin receptor Ab [Units/volume] in Serum
36
344
1.05
0.06
2.0
1.7
iu/l
5.7
4.9
—
9
109
(3010726) Horse dander IgE Ab [Units/volume] in Serum
11
121
0.91
0.06
1.0
1.0
u/ml
—
1.6
—
0
31
(3027944) Amphetamines [Presence] in Urine
19
201
0.94
0.04
4.6
1.7
—
—
—
0
0
(3003510) Neisseria gonorrhoeae DNA [Presence] in Urine by NAA with probe detection
61
623
0.98
0.03
1.6
1.6
—
—
—
0
0
(1001926) Buprenorphine [Presence] in Urine by Screen method
16
151
1.06
0.03
4.9
1.9
—
—
—
0
0
(3013603) Prostate specific Ag [Mass/volume] in Serum or Plasma
682
6836
1.00
0.02
4.8
5.3
ug/l
2.7
4.1
1.25
599
6050
(3016543) Leukocytes [#/volume] in Cerebral spinal fluid
35
358
0.98
0.01
1.4
1.3
e6/l
50.6
35.9
0.16
26
283
(3027475) Erythrocytes [#/volume] in Cerebral spinal fluid
35
358
0.98
0.01
1.5
1.4
e6/l
118.4
559.4
0.81
26
297
(3051593) INR in Capillary blood by Coagulation assay
12
114
1.05
0.00
7.5
15.4
—
—
—
0
0
(3032699) Streptococcus pneumoniae DNA [Presence] in Specimen by NAA with probe detection
13
124
1.05
0.00
2.0
1.4
—
—
—
0
0
(3019832) Treponema pallidum Ab [Presence] in Serum
61
604
1.01
0.00
1.5
1.4
—
—
—
0
0
(40759844) Sjogrens syndrome-B extractable nuclear Ab [Presence] in Serum by Immunoblot
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(40759843) Sjogrens syndrome-A extractable nuclear Ab [Presence] in Serum by Immunoblot
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(40759842) Ribonucleoprotein extractable nuclear Ab [Presence] in Serum by Immunoblot
11
109
1.01
0.00
1.1
1.1
—
—
—
0
0
(3010380) Borrelia burgdorferi IgG Ab [Units/volume] in Cerebral spinal fluid
15
151
0.99
0.00
1.1
1.1
—
—
—
0
0
(3027008) Opiates [Presence] in Urine
20
201
0.99
0.00
4.6
1.9
—
—
—
0
0
(21494670) JAK2 gene exon 14 targeted mutation analysis in Blood or Tissue by Molecular genetics method
21
209
1.00
0.00
1.1
1.1
—
—
—
0
0
(3027544) Mycobacterium sp identified in Sputum by Organism specific culture
23
231
1.00
0.00
3.4
3.7
—
—
—
0
0
(3016879) Cocaine [Presence] in Urine
19
186
1.02
0.00
4.8
1.9
—
—
—
0
0
(3004248) Sex hormone binding globulin [Moles/volume] in Serum or Plasma
36
356
1.01
0.00
1.4
1.8
nmol/l
35.5
41.7
0.99
36
336
(3037875) Bordetella parapertussis DNA [Presence] in Specimen by NAA with probe detection
10
102
0.98
0.00
2.1
1.5
—
—
—
0
0
(40764127) Haemophilus influenzae DNA [Presence] in Specimen by NAA with probe detection
10
102
0.98
0.00
2.1
1.5
—
—
—
0
0
(3024263) Appearance of Synovial fluid
10
102
0.98
0.00
1.4
1.4
—
—
—
0
0
(3011951) Aspergillus fumigatus IgE Ab [Units/volume] in Serum
11
112
0.98
0.00
1.1
1.2
u/ml
0.2
0.6
—
5
55
(3026725) Estradiol (E2) [Moles/volume] in Serum or Plasma
11
112
0.98
0.00
1.4
1.5
nmol/l
0.4
0.3
0.16
11
89
(3028300) Cannabinoids [Presence] in Urine
20
202
0.99
0.00
4.6
1.9
—
—
—
0
0
(4010399)
125
1253
1.00
0.00
1.6
1.4
—
—
—
0
0
(40759812) SCL-70 extractable nuclear Ab [Presence] in Serum by Immunoblot
11
107
1.03
0.00
1.1
1.1
—
—
—
0
0
(40759849) Smith extractable nuclear Ab [Presence] in Serum by Immunoblot
11
107
1.03
0.00
1.1
1.1
—
—
—
0
0
(40759836) Histone Ab [Presence] in Serum by Immunoblot
11
107
1.03
0.00
1.1
1.1
—
—
—
0
0
(3033093) Yersinia sp IgM Ab [Titer] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3011325) HIV 1+2 Ab [Presence] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(46236344) Yersinia enterocolitica O:9 IgG Ab [Presence] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(37020271) Myelin oligodendrocyte glycoprotein Ab [Titer] in Serum by Cell binding immunofluorescent assay
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3037441) Creatinine [Moles/volume] in Peritoneal dialysis fluid
0
7
0.00
0.00
0.0
5.0
—
388.6
—
0
7
(40758358) Immune stain study
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013466) aPTT in Blood by Coagulation assay
0
6
0.00
0.00
0.0
1.0
—
33.0
—
0
6
(3033086) Enterovirus NOS Ab [Titer] in Serum
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041293) ARIPiprazole [Mass/volume] in Serum or Plasma
0
6
0.00
0.00
0.0
1.5
—
—
—
0
0
(3038714) Yersinia pseudotuberculosis Ab [Titer] in Serum by Agglutination
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040668) CNBP gene mutations found [Identifier] in Blood or Tissue by Molecular genetics method Nominal
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3040944) Yersinia pseudotuberculosis 3 Ab [Titer] in Serum
0
6
0.00
0.00
0.0
1.0
—
—
—
0
0
(3039817) Yersinia enterocolitica IgA Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3042341) Yersinia pseudotuberculosis Ab [Presence] in Serum
0
6
0.00
0.00
0.0
2.0
—
—
—
0
0
(3031067) HIV 1 p24 Ag [Mass/volume] in Serum or Plasma by Immunoassay
0
7
0.00
0.00
0.0
1.0
—
—
—
0
0
(3000764) Benzodiazepines [Presence] in Urine
20
200
1.00
0.00
4.6
1.9
—
—
—
0
0
(3030429) Borrelia sp DNA [Identifier] in Specimen by NAA with probe detection
6
66
0.91
0.00
1.2
1.0
—
—
—
0
0
(3018688) Ampicillin IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(40763476) Honey bee phospholipase A2 recombinant (rApi m) 1 IgE Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3014114) Aureobasidium pullulans IgG Ab [Mass/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3035401) Herpes virus 6 DNA [Presence] in Specimen by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013762) Body weight Measured
0
8
0.00
0.00
0.0
1.5
—
—
—
0
0
(21494429) FMR1 gene CGG repeat analysis in Blood or Tissue by Molecular genetics method
0
5
0.00
0.00
0.0
1.2
—
—
—
0
0
(3023511) Choriogonadotropin [Units/volume] in Urine
6
67
0.90
0.00
1.3
1.3
—
—
—
0
0
(42868414) European tick borne encephalitis virus IgM Ab [Presence] in Serum by Immunoassay
6
67
0.90
0.00
1.0
1.2
—
—
—
0
0
(3048469) 10-Hydroxycarbazepine [Moles/volume] in Serum or Plasma
7
70
1.00
0.00
4.3
2.1
umol/l
60.7
53.7
—
7
53
(3030313) Adrenal Ab [Titer] in Serum
0
9
0.00
0.00
0.0
1.0
—
—
—
0
0
(3013924) Clostridium tetani IgG Ab [Units/volume] in Serum
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3015822) Parvovirus B19 DNA [Presence] in Serum by NAA with probe detection
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3016426) Methylmalonate [Moles/volume] in Serum or Plasma
0
5
0.00
0.00
0.0
1.2
—
230.2
—
0
5
(3000924) Streptococcus pyogenes [Presence] in Throat by Organism specific culture
7
78
0.90
0.00
1.0
1.1
—
—
—
0
0
(21492888) Glucose tolerance 2 hours gestational panel - Serum or Plasma
5
50
1.00
0.00
1.2
1.5
—
—
—
0
0
(44806420)
7
78
0.90
0.00
1.7
2.3
—
—
—
0
0
(46234834) Bacteria identified in Bone by Anaerobe+Aerobe culture
0
8
0.00
0.00
0.0
1.1
—
—
—
0
0
(3042301) Urate [Moles/volume] in Synovial fluid
0
5
0.00
0.00
0.0
1.0
—
—
—
0
0
(3041145) Herpes simplex virus IgM Ab [Presence] in Serum by Immunoassay
8
85
0.94
0.00
1.1
1.1
—
—
—
0
0
(3044212) Herpes simplex virus 1+2 IgM Ab [Presence] in Cerebral spinal fluid
5
56
0.89
0.00
1.0
1.2
—
—
—
0
0
(3028679) Herpes simplex virus Ab [Presence] in Serum
5
59
0.85
0.00
1.0
1.1
—
—
—
0
0
(3006044) Creatine kinase.total/Creatine kinase.MB [Enzymatic activity ratio] in Serum or Plasma
0
8
0.00
0.00
0.0
1.4
—
2.6
—
0
8
(3005136) Cladosporium herbarum IgE Ab [Units/volume] in Serum
8
86
0.93
0.00
1.0
1.0
—
0.4
—
0
23

Mortality – FinRegistry

↥

This endpoint is excluded from FinRegistry analyses (omitted endpoint).

Relationships between endpoints

↥

Index endpoint: OPER_JFB30 – Right hemicolectomy

GWS hits: -

This endpoint is excluded from FinRegistry analyses (omitted endpoint).